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Lipids, in all their forms from structural components of the membranes 
(phosphoglycerides, glycolglycerolipids) to signaling molecules (IP3, DAG, 
prostaglandins, etc.,) post-translational modification of proteins (palmitoylated, 
farnesylated, prenylated, and GPI anchoring) play an essential role in cancer cell 
survival, proliferation, and metastasis. Alteration in structural lipids can impair 
transport, and signaling cascades.  Abnormalities in lipids, such as cardiolipin 
(Ptd2Gro), impair mitochondrial function, bioenergetics, and could play a role in 
precipitatting the high incidence of spontaneous tumors in VM/Dk mice. This 
thesis explores the role of glucose and glutamine in their incorporation into lipids 
in the VM-M3 murine glioblastoma cell line as well as the inheritance of brain 
cardiolipin fatty acids abnormalities in VM/Dk mice.  I used labeled [14C]-U-D-
glucose and [14C]-U-L-glutamine to examine the profile of de novo lipid 
biosynthesis in the VM-M3 cell line.  The major lipids synthesized included 
phosphatidylcholine (PtdCho), phosphatidylethanolamine (EtnGpl), 
phosphatidylinositol (PtdIns), phosphatidylserine (PtdSer), sphingomyelin 
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(CerPCho), bis(monoacylglycero)phosphate (BMP) / phosphatidic acid (PtdOH), 
cholesterol (C), Ptd2Gro, and the gangliosides.   The data show that the 
incorporation of labeled glucose and glutamine into synthesized lipids was 
dependent on the type of growth environment, and that the VM-M3 glioblastoma 
cells could acquire lipids, especially cholesterol, from the external environment 
for growth and proliferation. 
  
In addition, this thesis also explores and evaluates the abnormality of 
Ptd2Gro fatty acid composition in VM mice in comparison to B6 mice. Although 
previously reported, I confirmed the finding in the abnormal cardiolipin fatty acid 
composition in the VM mice. The abnormal brain cardiolipin fatty acid 
composition was found to be inherited as an autosomal dominant trait in 
reciprocal B6 x VM F1 hybrids for both male and female.  Impaired cognitive 
awareness under hypoxia observed for the VM mice and reciprocal F1 hybrids is 
associated with abnormalities in neural lipid composition. 
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Ye shall eat no fat, of ox, or sheep, or goat. And the fat of that which dieth of itself, and the fat of 
that which is torn of beasts, may be used for any other service; but ye shall in no wise eat of it. 
For whosoever eateth the fat of the beast, of which men present an offering made by fire unto the 
Lord, even the soul that eateth it shall be cut off from his people” (Leviticus 7:23-25). 
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CHAPTER ONE 
 
Introduction 
 
Lipids and their metabolism in cancer 
 
Lipids, derived from the Greek word lipos, are among the four essential 
components that make up a cell.  Unlike nucleic acids and proteins, lipids do not 
form secondary or tertiary structures and are not polymeric as seen in 
polysaccharides.  However, the amphipathic properties, of phospholipids, form 
the lipid bilayers of plasma and organelle membranes.  The saturation, 
unsaturation and chain lengths determine physicochemical properties of the fatty 
acids.  The long hydrocarbon chains can serve as the major energy stores. They 
also play a major role in cellular signaling and post-translational modification of 
proteins.  Sterols, such as cholesterol, play a major role in the fluidity of the lipid 
bilayer.  All animal and plant cells contain cholesterol in their membranes.  
Cholesterol and phospholipids are critical for processes such as cell division, 
besides DNA synthesis, replication, and protein synthesis.  Lipid composition of 
various membranes (plasma, mitochondria, ER, nuclear, lysosomal, etc.) 
consists of a particular lipid : cholesterol ratio.  Moreover, there is specificity to 
inner or outer leaflets of the membrane or higher content of particular lipids or 
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cholesterol for a particular membrane type.  For instance, plasma and lysosomal 
membranes consist of the highest content of cholesterol while mitochondria have 
the least amount of cholesterol, particularly the inner mitochondrial membrane 
(Colbeau et al. 1971, Hackenbrock et al. 1980).  However, the inner membrane 
of mitochondria consists of higher mole percentage of Ptd2Gro in comparison to 
other membranes (Daum 1985).   
 
There are three principle classes of lipids: glycerophospholipids (Figure 1a), 
sphingolipids (including glycosphingolipids) (Figure 1b), and sterols (Figure 1c). 
De novo lipid synthesis begins from the transport of mitochondrial citrate to the 
cytosol to be converted to acetyl CoA.  The bifurcation of acetyl CoA into either 
malonyl CoA or acetoacetyl CoA leads to fatty acid or cholesterol synthesis, 
respectively (Figure 2).  The committed step in the conversion of acetyl CoA to 
malonyl CoA is carried out by acetyl CoA carboxylase (ACC).  Condensation of 
malonyl CoA with acetyl CoA and repeated condensations with acetyl CoA is 
carried out by fatty acid synthase (FASN) in the formation of palmitic acid 
(C16:0).   Palmitic acid can either be elongated and/or desaturated to make 
longer unsaturated fatty acids.  Fatty acyl CoA can then be transferred to 
glycerol-3-phosphate (G-3-P) to form lysophosphatidic acid (lysoPtdOH), and 
then phosphatidic acid (PtdOH).  Although PtdOH is only found in small 
quantities in the membrane, it represents the precursors for all phospholipid 
synthesis, as well as triacylglycerol (TAG).  PtdOH can either react with cytidine 
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triphosphate (CTP) to form cytidine diphosphate diacylglycerol (CDP-DAG) or 
dephosphorylated to diacylglycerol (DAG).  DAG serves as the precursor for 
neutral glycerophospholipids: phosphatidylcholine (PtdCho), and 
phosphatidylethanolamine (EtnGpl).  CDP-DAG serves as the precursor for 
acidic, anionic glycerophospholipids: phosphatidylserine (PtdSer), 
phosphatidylinositol, (PtdIns), phosphatidylglycerol, (PtdGro), and cardiolipin 
(Ptd2Gro).  Sphingolipid synthesis begins with the condensation of serine and 
palmitoyl CoA to form 3-ketosphingosine.  This is the precursor for ceramide 
(Cer), sphingomyelin (CerPCho), and glycosphingolipids (gangliosides).    
Alternatively, acetyl CoA can be diverted for cholesterol (C) biosynthesis via the 
mevalonate pathway (Figure 2). 
 
Structural lipids, such as Ptd2Gro, located in the inner membrane of the 
mitochondria membrane, can directly associate with electron transport chain 
(ETC) enzymes and influence the enzymatic activities.  Aberrant Ptd2Gro content 
and fatty acid (FA) composition were found in all the tumors that were analyzed 
(Kiebish et al. 2007).  Ether lipids, i.e. plasmalogens, are linked to cancer 
pathogenicity, motility, and growth (Benjamin et al. 2013).  The bioactive 
sphingosine-1-phosphate (S1P) stimulates motility, and proliferation through 
activation of ERK1,2, neovascularization, and the Bcl-2 family (Pyne et al. 2010, 
Abuhusain et al. 2013). Ceramides have been shown to be reduced in some 
cancer cells and they are a critical mediator in tumor cell resistance to apoptosis 
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(Morad et al. 2013)   Signaling molecules such as IP3, and DAG have been 
widely shown in signaling pathways involving PKC, and G-protein coupled 
receptors (GPCR).  Post-translational modification (i.e. prenylation of Ras 
GTPases, or GPI anchored of urokinase-type plasminogen activator (uPA) and 
its receptor (uPAR)) anchors designated proteins to the membranes and is  
associated with protein activation status and signal transduction (Bergum et al. 
2012, Gorfe 2010).  Glycosphingolipids are components of the cellular 
membrane that can be shed to the tumor microenvironment and that can 
influence angiogenesis. On the one hand, GD3 (alphaNeu5Ac(2-8)aNeu5Ac(2-
3)bDGalp(1-4)bDGlcp(1-1)Cer) can promote tumor angiogenesis in human 
gliomas (Alessandri et al. 1987, Koochekpour et al. 1996), but on the other hand 
GM3 (alphaNeu5Ac(2-3)bDGalp(1-4)bDGlcp(1-1)Cer) can repress the 
angiogenic response (Tagami et al. 2002, Fujimoto et al. 2005, Seyfried et al. 
2010a) and tumor progression (Song et al. 1991, Rebbaa et al. 1996, Choi et al. 
2006, Nakatsuji et al. 2001).  Levels of expression and distribution of particular 
glycosphingolipids are associated with the tumor angiogenic properties (Ziche et 
al. 1992, Jennemann et al. 1994). 
 
Deregulation of lipid metabolism in cancer is often involved with high expression 
activity of enzymes involved in the lipid synthesis pathway, i.e., ATP citrate lyase 
(ACLY), ACC, FASN, and steroyl CoA desaturase –1 (SCD-1) (Menendez et al. 
2007, Santos et al. 2012, Fritz et al. 2010, Mason et al. 2012, Roongta et al. 
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2011).  Overexpression of fatty acid synthase (FASN) and ACLY is considered 
important in the pathogenesis and the proliferative capacity of the neoplastic cells 
(Pizer et al. 1998b, Pizer et al. 1996).  Hence, inhibition or silencing of ACLY has 
been shown to be effective in reducing tumor growth (Hatzivassiliou et al. 2005, 
Bauer et al. 2005).  Hochkacha proposed the lipogenic benefit of the cancer cells 
was to improve the redox balance due to the aerobic fermentation phenomenon 
in cancer cells (Hochachka et al. 2002).  Lipid oxidative enzymes and pathways 
have also been linked to the characteristics of cancer phenotypes (Liu 2006, 
Nomura et al. 2010).  Monoacylglycerol lipase (MAGL) was found to be higher in 
the aggressive tumors and thought to maintain the malignant properties by 
liberating free fatty acid (FFA) from glycerophospholipids in generating lipid 
mediators, such as prostaglandin E2 (PGE2) and lysoPtdOH (Nomura et al. 
2010, Mills et al. 2003).  
 
Hypoxia and its influences on lipid metabolism 
 
Typically, non-cancerous proliferating cells, i.e., regenerating liver cells or 
hematopoietic stem cells proliferate or differentiate in a well defined manner with 
controlled regulations of their growth.  On the other hand, tumor cells proliferate 
in an uncontrolled manner in such that it can lead to their own demise.  The 
uncontrolled growth can distance the central core of the tumor mass from 
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oxygen, and nutrients from blood vessels.  The limitation of oxygen and nutrients 
often result in necrotic cell death in the inner core of a tumor mass.  Yet, the 
unintended self-imposed hypoxic environment initiates a major adaptation to the 
deficient environment by activating hypoxia inducible factor – alpha (HIF1-alpha).  
Activation of HIF1-alpha mediates transcription of genes to ensure their survival.  
Among the obvious and well-known activated genes are AKT, glycolytic 
enzymes, lactate dehydrogenase A (LDH-A) and vascular endothelium growth 
factor (VEGF) to further enhance the glycolytic activities, formation of new blood 
vessels and prevention of apoptosis (Semenza et al. 1996, Mathupala et al. 
2001, Alvarez-Tejado et al. 2001).  HIF1-alpha activation also leads to the 
reduction of mitochondrial biogenesis via the suppression of peroxisome 
proliferator-activated receptor coactivator (PGC) and induction of autophagy 
through a BNIP3 - Beclin-1 dependent mechanism (Zhang et al. 2008, Zhang et 
al. 2007, Mazure et al. 2009).  Hypoxia also induces alteration in glycolyl 
attachment to E-cadherin that may aide in tumor cell extravasation for metastasis 
(Koike et al. 2004). Other, less well known, but as important effects, are enzymes 
involving lipid metabolism.  Hypoxia induces the activation of FASN through 
SREPB-1 and AKT dependent mechanisms (Furuta et al. 2008).  Hypoxia 
induces the transcription of the sialin gene and enhances the attachment of 
NeuGc (N-glycolyl neuraminic acid) sialic acid (acquired from the external milieu) 
to gangliosides in human tumors which are normally attached with NeuAc (N-
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acetylneuraminic acid).  The ceramide moiety of the ganglioside portion was also 
found to be modified with decreased level of unsaturation (Yin et al. 2010). 
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Figures 
 
Figure 1.  Three principle classes of lipids  
Three principle classes of lipids: glycerophospholipids (a), sphingolipids (b), and 
sterols (c).  Adapted from the AOCS Lipid Library. 
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Figure 1 
 
 
a. 
 
 
 
b. 
 
 
 
c. 
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Figure 2. Schematic diagram of acetyl Co-A derived citrate bifurcated route into 
synthesis of fatty acid or cholesterol biosynthesis 
Schematic diagram of acetyl Co-A derived citrate bifurcated route into synthesis 
of fatty acid or cholesterol biosynthesis 
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Figure 2	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CHAPTER TWO 
 
 
Influence of serum and hypoxia on incorporation of [14C]-U-D-glucose or 
[14C]-U-L-glutamine into lipids and lactate in murine glioblastoma cells 
 
 
Introduction 
 
Glioblastoma multiforme (GBM) is among the most aggressive of all brain tumors 
that often leads to morbidity and death within 12-15 months despite the best 
available treatments (Wen et al. 2008, Seyfried et al. 2014).  Malignant gliomas, 
similar to other tumor types, have aberrant metabolism of glucose and glutamine 
(Portais et al. 1996, DeBerardinis et al. 2007).  Enhanced glycolytic fermentation 
in the presence of oxygen (Warburg effect) and glutamine utilization are common 
metabolic features of glioma cells whether grown in vitro or in vivo (DeBerardinis 
et al. 2007, Wolf et al. 2010, Maher et al. 2012, Qu et al. 2012, Gambhir 2002).  
The conversion of glucose into lactate rather than complete oxidation through the 
TCA cycle helps in regenerating the NAD+ that is required for production of 
anabolic intermediates and ATP through glycolysis (Vander Heiden et al. 2009, 
Lunt et al. 2011).  These metabolic substrates are also involved in the anabolic 
requirement of lipid biosynthesis in proliferating glioma cells (DeBerardinis et al. 
2007).   
	  	  
13	  
Lipids play an essential role in the survival, proliferation, and metastasis of tumor 
cells (Park et al. 2012, Mills et al. 2003, Karmali 1986, Wang et al. 2006, Rolin et 
al. 2011, Kamphorst et al. 2013, Chang et al. 2004, Clendening et al. 2010).  Ex 
vivo culture of human gliomas showed significant synthesis of choline and 
ethanolamine plasmalogens, with less synthesis of the structurally complex 
gangliosides (Yates et al. 1979).  More recently, tracer studies using [13C] 
glucose and [13C] glutamine with LC/MS have only evaluated palmitate synthesis 
(DeBerardinis et al. 2007, Scott et al. 2011), but not to the synthesis of individual 
phospholipids or glycosphingolipids (gangliosides).  
 
Lipogenesis in cancer is coupled to glucose and glutamine metabolism 
 
Endogenously synthesized fatty acids can be derived from one of the three 
precursors: glucose, glutamine, and acetate.  Enhanced glucose uptake, first 
posited by Warburg in 1927 (Warburg et al. 1927), has long been accepted and 
the principle is still being used at the present time to detect tumors in vivo by 2-
deoxy-2(18F)fluoro-D-glucose – PET imaging.    Aerobic glycolysis exhibited in 
tumor cells is considered as one of the major hallmarks in tumor cell metabolism.  
The conversion of glucose into lactate rather than coupling it to TCA and ETC, 
helps in regenerating the NAD+ that is required for continued glycolytic activity 
(Figure 3).  Enhanced glycolytic flux satisfies the demand of ATP due to the 
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suppression of mitochondria.  In addition, it also provides anabolic intermediates 
for macromolecules synthesis through the generation of nucleotides from the 
pentose phosphate pathway (PPP) or glycerol-3-P for lipid biosynthesis.  As 
Costello and Franklin pointed out “if bioenergetics were the important metabolic 
concern of the tumour cells as is often proposed, the ‘anoxic glycolytic’ pathway 
would be a costly adaptation (Costello et al. 2005).  They proposed the enhanced 
aerobic glycolytic flux could be due to supplying the pool of acetyl CoA for 
lipogenesis in demand for tumor cells to proliferate  
 
Glutamine can serve as an anaplerotic substrate, in replenishing the TCA cycle 
intermediates particularly α-ketoglutarate, and oxaloacetate, or be oxidized in 
generation of ATP.  Alternatively, glutamine is not fully oxidized to CO2, but 
converted to lactate or alanine by malic enzymes in producing NADPH.  This 
metabolic flux of glutamine metabolism is what considered as glutaminolysis, as 
proposed by Mckeehan (McKeehan 1982).  As early as 1979, Reitzer et al 
demonstrated that glutamine was used as a major energy source for Hela cells, 
and not sugar (Reitzer et al. 1979).  The authors also found a significant portion 
of glutamine was converted to lactate.  Similar observations were put forth by 
DeBerardinis that 60% of glutamine was metabolized to lactate in SF188 human 
glioblastoma cell line (DeBerardinis et al. 2007).  The conversion of glutamine to 
lactate through cytosolic malic enzymes was hypothesized to synthesize ample 
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of NADPH to support lipid biosynthesis. Alternatively, glutamine can enter the 
truncated TCA cycle in which α-ketoglutarate generates and sequentially in 
generating citrate.  Exported citrate to the cytosol is converted to acetyl CoA for 
FA synthesis and the generation of extramitochondrial malate.  This pool of 
malate can re-enter the mitochondria and be converted back to pyruvate via 
mitochondrial malic enzyme.  Pyruvate is then converted to acetyl CoA and 
condensed with oxaloacetate to citrate (Figure 3) (Kovacevic et al. 1983, 
Moreadith et al. 1984, Piva et al. 1998).  This also allows the generation of GTP 
via substrate level phosphorylation.  Hence, it is still unclear how glutamine is 
being fluxed through which pathway.   
 
The misconception: Cancer cells synthesize all their lipids endogenously 
 
The thematic interest in the dependency of tumor cells to endogenously 
synthesize their own lipids for the sake of proliferation has been misconstrued 
and misinterpreted.  For instance, Weljie et al. express this in their statement 
referencing a paper from Medes et al. (1953), “Although normal cells (other than 
in liver and adipose tissue) rarely use de novo synthesis, instead acquiring fatty 
acids from dietary sources, the majority of fatty acids produced by tumor cells are 
not derived from dietary sources. Indeed, an important observation in this area 
was made as a result of labeling studies that indicated that de novo fatty acid 
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synthesis was the primary source of tumor lipids, in spite of the availability of 
exogenous FA pools” (Weljie et al. 2011). Similarly, in a Nature Review article 
published in 2007, Menendez and Lupu cited the same paper, stating “practically 
all esterified FAs in tumor models were derived from de novo synthesis” 
(Menendez et al. 2007).  The direct quote in the summary of Medes et al. paper 
in 1953 concludes otherwise: “A study of lipogenesis in neoplastic tissues has 
shown that acetate and glucose carbon can be utilized for synthesis of fatty acid 
chain.  However, the data indicate that this process is probably too slow to supply 
the lipid needs of a rapidly growing tumor, and the tumor must therefore obtain its 
lipids preformed from the host” (Medes et al. 1953).  Lipids preformed from the 
host are primarily triglycerides, free fatty acids, and lipoprotein complexes 
(cholesterol, cholesteryl esters, and triglycerides).  There are tumors, arising from 
liver, breast, ovary, prostate that exhibit lipogenic phenotype with enhanced 
lipogenic gene signatures (Beckers et al. 2007, Swinnen et al. 2006, Milgraum et 
al. 1997, Pizer et al. 1996).  Inhibition of de novo lipogenesis with FASN, ACC 
inhibitors in vivo exerts antitumor effect in rodent models for these tumor types 
(Alli et al. 2005, Kridel et al. 2004, Chen et al. 2012, Pizer et al. 1998a).  
Ironically, even some of these lipogenic tumor types also have increased 
expression of lipoprotein lipases (LPL), and CD36.  These are enzymes that are 
related to the uptake of lipids into the cells (Kuemmerle et al. 2011).  Efficient 
utilization of FA or LDL requires the expression of CD36 and LPL. CD36 
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expression was found to be positive in 80% of breast and liposarcoma tumor 
tissues, and 50% for prostate tumor tissues (Kuemmerle et al. 2011).  
 
Our goal here was to examine the influence of fetal bovine serum (FBS), which 
contains large amounts of lipids (Stoll et al. 1984, Rothblat et al. 1976) on lipid 
biosynthesis derived from [14C]-U-D-glucose and [14C]-U-L-glutamine in the 
metastatic murine glioblastoma cell line (Huysentruyt et al. 2008a).	   	  Additionally, 
we evaluated the influence of hypoxia on lipid biosynthesis using uniformly 
labeled glucose and glutamine.  The current study identified an increase in lipid 
biosynthesis when cells were deprived of FBS.  This study also confirmed the 
high rate of aerobic glycolysis, with high lactate derived from glucose.  However, 
minimal lactate was derived from labeled glutamine.  The attenuation of glucose 
entering the TCA cycle under hypoxia leads to a compensatory increase of 
glutamine utilization for lipid biosynthesis.  In addition, hypoxia induced 
accumulation of triglycerides and increased the level of saturated and 
monounsatured fatty acids. 	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Materials and Methods 
 
Chemicals  
 
[14C]-U-D-glucose was purchased from MP Biomedicals (Fountain parkway, OH), 
and  [14C]-U-L-glutamine was from Perkin Elmer (Boston, Ma).  Lipid standards 
were either purchased from Matreya (Pleasant Gap, PA), Sigma (St. Louis, MO), 
or from Nu-Chek Prep (Elysian, MN).  Antimycin A, Oil Red O, acetyl chloride 
were from Sigma.  Primulin and lipoprotein were from MP Biomedicals.  DEAE 
Sephadex (A-25) for column chromatography was obtained from GE Healthcare 
(Uppsala, Sweden).  HPTLC plates (10 x 20 cm and 20 x 20 cm) were from 
Merck kGaA (Darmstadt, Germany).  All developing solvents are of ACS and 
HPLC reagent grade, and purchased either from Sigma, or Fisher Scientific (Fair 
Lawn, NJ).   
 
Origin of VM tumors 
 
VM-M3 microglial tumor cell line arose spontaneously from VM/Dk (VM) mice 
after routine examination of the colony over a period of 7 years.  Specifically, VM-
M3 was derived from the cerebrum of an adult VM mouse. 	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Cell culture and treatment 
 
The VM-M3 glial tumor cell line was established from a mouse of the VM/Dk 
inbred strain as previously described (Huysentruyt et al. 2008b).  Cells were 
grown in Dulbecco’s modified Eagle medium (DMEM) (Sigma, St. Louis MO) with 
glucose (25 mM) and glutamine (4 mM) and 50 µg/ml penicillin/streptomycin 
(Sigma).  10% fetal bovine serum (FBS) (Hyclone Thermo Scientific, Waltham, 
MA) was supplemented where indicated.  All cells were cultured in a humidified 
incubator containing 5% CO2 at 370C.  Cells were either grown in the presence or 
absence of 10% FBS as well as under normoxia (21% O2) or under 0.1% O2 
(hypoxia) using hypoxic chamber (Biospherix) equilibrated with N2.  Cells were 
seeded equally in 150 x 25 mm culture dishes and were cultured for 48 hrs in 
medium containing either 0.15 mCi/mL [14C]-U-D-glucose or [14C]-U-L-glutamine, 
both at final concentration of 0.05 µmol/ml. The cells were collected, rinsed with 
PBS, and counted by trypan blue dye exclusion before lipid extraction. 
 
Lipid isolation, purification, and quantification 
 
Neutral lipids, acidic lipids, and gangliosides were isolated and purified from 
lyophilized cell pellets by modified procedures previously described (Seyfried et 
al. 1978, Baek et al. 2004).  Briefly, total lipids were extracted with chloroform 
(CHCl3) and methanol (CH3OH) 1:1 vol/vol.  Neutral and acidic lipids were 
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separated using DEAE-Sephadex column chromatography as previously 
described (Macala et al. 1983, Kasperzyk et al. 2005).  The total lipid extract, 
suspended in CHCl3:CH3OH:dH20, 30:60:8 by volume (solvent A), was applied to 
a DEAE-Sephadex column (1.2 mL bed volume) that had been equilibrated prior 
with solvent A.   Neutral lipids were eluted with two 20 ml washes of solvent A.  
The acidic lipids and gangliosides were eluted from the column with 35 mL 
CHCl3:CH3OH: 0.8 M sodium acetate, 30:60:8 by volume (solvent B).  
Gangliosides were separated from acidic lipids as previously described (Seyfried 
et al. 1978, Kasperzyk et al. 2004, Macala et al. 1983). 
 
Individual lipids were separated by high performance thin-layer chromatography 
(HPTLC) according to previously described methods (Macala et al. 1983).  For 
neutral and acidic phospholipids, the plates were developed to a height of 4.5 cm 
or 6.0 cm, respectively with chloroform: methanol: acetic acid: formic acid: water 
(70:30:12:4:2 by volume), and developed to the top with hexanes: diisopropyl 
ether: acetic acid (65:35:2 by volume).  For gangliosides, the plates were 
developed using chloroform: methanol: 0.02% aqueous calcium chloride 
(55:45:10 by volume).  Radiolabeled lipids were developed using Kodak 
Phosphor screen and visualized using Phosphoimager STORM 820 (GE 
Healthcare) and quantitated by densitometric determination with ImageQuant TL 
software.  Total non-labeled lipids were visualized by charring with 3% cupric 
acetate in 8% phosphoric acid solution, followed by heating in an oven at 1650 C 
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for 7 min for neutral and acidic lipids.  Total non-labeled gangliosides were 
visualized by spraying the plates with resorcinol-HCL reagent, followed by 
heating at 1000 C for 10 min.   
 
Distribution and quantification of total and radiolabeled lipids 	  
The distribution of total and radiolabeled lipids was determined after 
densitometric determination of individual lipids that has been resolved by HPTLC 
using ImageQuant TL.  The percent distribution of an individual lipid was 
calculated and displayed as the mole percent of that lipid to the entire 
compilation of lipids in neutral, acidic lipids, and ganglioside fractions.  The 
disintegration per minute (dpm) value of newly synthesized lipids was determined 
by liquid scintillation counting in 7 mls of Ecosint A with the Tri-Carb liquid 
scintillation counter (Perkin Elmers).  The amount of 14C incorporation into each 
individual lipid was determined by applying the PhosphorImager determined 
percentage distributions mulitiply by the total scintillation counter estimations of 
total radioactivity present in the neutral, acidic, or ganglioside fractions. 
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Preparative HPTLC, gas liquid chromatography (GLC) and ESI/MS analysis 
of triacylglycerols (TAG) 
 
Neutral lipid fractions were isolated as described above.  The entire neutral lipid 
fraction was used for preparative high performance thin-layer chromatography 
(10 x 20 cm) to separate triglycerides from phospholipids, and cholesterol.  The 
plate was developed in a single solvent system containing hexanes: diethyl ether: 
acetic acid (70:30:1). A purified TAG standard (Sigma) was used to identify the 
TAG band from samples.  Lipids were visualized by spraying the plate with 
0.05% primulin (80:20 acetone: water vol/vol).  The TAG fraction was scraped 
from the plate and trans-esterified with acetyl chloride in methanol (1:50 by 
volume) for 45 min in a sealed boriscilicated glass tube under nitrogen at 900 C.  
Gas chromatography (HP 6890) equipped with flame ionization detector and 
splitless injector was used for the quantitative analysis of the fatty acid methyl 
esters.  The fatty acids were resolved using a 30 m x 0.25 mm x 0.25 µm 
Omegawax 250 fused silica capillary column (Supelco). The temperature 
program increased from 150oC to 2200C at 2oC per minute and was held 
constant at 2200C for 20 min. 
 
ESI tandem mass spectrometry was carried out with the help of Dr. Kiebish at 
Berg Diagnostics.  Briefly, lipids were extracted with a modified Bligh and Dyer 
procedure, and analyzed using AB SCIEX 5600+ TripleTOF mass spectrometry. 	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Lactate measurement 
 
Lactate was analyzed from the culture media.  L-lactate (Sigma) was used to 
confirm the lactate band by visualizing it with bromocresol green.  An equal 
amount of media (250 µl) was lyophilized and re-suspended in 60 µl of methanol 
and spotted on HPTLC (20 x 20 cm).  The plate was developed in a single 
solvent system with butanol: acetic acid: water (50:11:25 by volume) for 5 hours.  
Autoradiography visualization and densitometric scanning were performed as 
previously described. 
 
Oil Red O staining for triacylglycerols 
 
A 0.7% solution of Oil Red O in a 2-propanol stock solution was diluted with 
water (3:2, v/v) and filtered before use.  Cells were grown directly on slide cover 
slips embedded inside a culture dish (100 x 20 mm) (BD Falcon).  Cells were 
either grown in atmospheric oxygen (21% O2), 0.1% O2, or 0.1 µM antimycin 
(AA).  Cells were then washed with PBS, fixed for 5 min with 3.7% 
paraformaldehyde in PBS, and incubated with Oil Red O for 20 min.  Cells were 
rinsed 3 x with PBS before visualization using phase contrast microscopy (Zeiss 
Axioplan 2.) 
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Determination of triacylglyerol content in subcutaneous implanted VM 
tumor  
 
VM-M3 tumor fragments were diced in cold PBS at pH 7.4.  VM male mice (3 
months of age) were anesthesized with isoflurane (Halocarbon, NJ) and 0.1 ml of 
the diced tumor tissue was implanted subcutaneously (s.c.) in the left flank using 
a 1 cc tuberculin syringe and 18-gauge needle.  The inoculated mice were 
housed together with free access to food and water.  After a period of 30 days, 
tumors were removed from the flank and sliced into three distinct areas of the 
tumor designated as inner, middle, and outer core of the tumor.  Each of the  
three regions of the tumors from three different mice was subjected to lipid 
isolation in determining the triacylglycerol content. 
 
 
Statistical analysis 
 
Interquartile range was used as error bars in experiments with only two samples. 
Otherwise, the two-tailed t test or ANOVA was used to calculate statistical 
significance using SPSS version 21.  A p value of less than 0.02 was considered 
to be significant. 
 
 
 
 
 
  
	  	  
25	  
Results 
 
Influence of FBS on lipid distribution and incorporation of [14C]-U-D-
glucose and [14C]-U-L-glutamine in VM-M3 glioblastoma cells 
 
Neutral Lipids 
 
The influence of FBS on the relative distribution of total neutral lipids in the VM-
M3 cells, visualized with HPTLC charring, is shown in Table 1 and Figure 3 (the 
charring of the HPTLC was done after visualization of radioactive lipids).  The 
data showed that the relative distribution of all major lipids was similar with two 
samples from either labeled glucose or labeled glutamine.  Hence the data was 
combined to only show FBS as the experimental factor.  
 
The relative distribution of all neutral lipids was similar in the presence or 
absence of FBS (Table 1, Figure 4).   Cholesterol comprised ~ 27% of the total 
lipids.  EtnGpl, and PtdCho, represented ~ 21% individually of the total lipids, 
while CerPCho was at ~ 10%, Cer, and TAG ~ 6% each. LysoPtdCho was only 
minimally detected.   
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FBS had a major influence on de novo neutral lipid biosynthesis and distribution 
using labeled carbons from either glucose or glutamine (Table 2, Figure 5, Figure 
6).   
 
The incorporation of either glucose or glutamine carbons into the neutral lipids 
was markedly greater in the absence (8100 ± 931 dpm, and 4574 ± 44 dpm) than 
in the presence of FBS (4574 ± 44 dpm and 2557 ± 131 dpm, respectively) 
(Table 2).  While cholesterol comprised ~ 27% of the total neutral lipids in the 
presence or absence of FBS (Table 1), cholesterol comprised only ~ 8% and 
10% of the neutral lipids synthesized from labeled glucose or glutamine, 
respectively, in the presence of FBS (Figure 4, Figure 5). Cholesterol synthesis 
increased to about 14% and 12%, respectively, in the absence of FBS.  These 
findings indicate that cholesterol could be obtained exogenously from the FBS 
and that cholesterol synthesis increased in the absence of FBS.  PtdCho 
represented ~ 21% of the total neutral lipid distribution (Table 1), but increased to 
~ 38% of the radiolabeled neutral lipids (Figure 4, Figure 5).  The relative 
distribution of the other radiolabeled neutral lipids was similar to their distribution 
in the total neutral lipid fraction, but overall synthesis was greater in the absence 
than in the presence of FBS using either glucose or glutamine carbons.   
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Acidic Lipids 
 
Similar to neutral lipids, relative distribution of total acidic lipids was similar in the 
presence or absence of FBS (Table 3, Figure 7).  PtdSer comprised of c.a. 
38.0% of the total acidic lipids, while PtdIns was comprised at c.a. 32%, Ptd2Gro 
at c.a. 10%, followed by BMP/PtdOH at c.a. 8%, and PtdGro at c.a. 4%.  FBS 
also had a major influence on de novo acidic lipid biosynthesis using labeled 
carbons from either glucose or glutamine (Table 4, Figure 8, Figure 9).  The 
incorporation of either glucose or glutamine carbons into the acidic lipids was 
markedly greater in the absence (4721 ± 337 dpm, and 3077 ± 128 dpm,) than in 
the presence of FBS (3247 ± 301 dpm and 1667 ± 71 dpm, respectively) (Table 
4).  Similar to total lipids, PtdIns and PtdSer were the major acidic phospholipids 
expressed in the VM-M3 cells (Figure 8).  Lower amounts of Ptd2Gro, 
BMP/PtdOH, and PtdGro were also synthesized.   Despite the overall increased 
synthesis of the individual acidic lipids in the absence of FBS, the relative 
distribution of these lipids was similar in the presence or absence of FBS, with a 
minor reduction of PtdOH/BMP, and PtdSer in the absence of FBS (Figure 8). 
 
Overall, the incorporation of either glucose and glutamine carbons into both 
neutral and acidic lipids was greater in the absence than in the presence of FBS.  
In addition, lipid biosynthesis using glucose carbons is about 2-fold greater than 
biosynthesis using glutamine carbons (Figure 10). 
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Gangliosides 
 
The relative distribution of total gangliosides was similar in the presence or 
absence of FBS (Table 5, Figure 11). Gangliosides GD1a, GM1, and GM2 were 
the three major species present in both the non-labeled and the labeled lipid 
fractions (Figure 11, Figure 13).   The distribution of these gangliosides was 
similar in the presence or absence of FBS for both total and radiolabeled lipids 
(Table 5, Figure 12) but total radiolabeling was greater using carbons from 
glucose than from glutamine (Table 6).  This observation is expected in 
gangliosides since the carbons from glucose can be incorporated into the 
carbohydrate, sphingosine, and fatty acids of gangliosides, whereas the carbons 
from glutamine will be incorporated largely into the fatty acyl components of 
these lipids.  
 
Influence of FBS on lactate production from radiolabeled glucose or 
glutamine carbons 
 
The lactate produced in the VM-M3 cells was derived largely from glucose in 
either the presence or absence of FBS (Figure 14 A, B).   However, lactate 
production from glucose was less in the absence than presence of FBS 
suggesting a diversion of glucose carbons from lactate synthesis to lipid 
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synthesis.  Only minor amounts of lactate were derived from labeled glutamine 
carbons in either the presence or absence of FBS.  These findings indicate that 
glutamine carbons contributed very little to the lactate pool in these cells.  
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Influence of hypoxia on lipid distribution and incorporation of [14C]-U-D-
glucose and [14C]-U-L-glutamine in VM-M3 glioblastoma cells 
 
Neutral Lipids 
 
The influence of hypoxia on total neutral lipids in the VM-M3 cells is shown in 
Figure 15.  In order to visualize qualitative changes of lipids, particularly 
triacylglycerols and cholesterol, under hypoxia, an equal amount of disintegration 
per minute (dpm) were spotted on the HPTLC plate for comparison.  Here, 
approximately 3000 dpm were spotted for the neutral lipids, rather than equal 
number of cells.  However the calculated dpm as shown in Table 7 is normalized 
to the same number of cells.   
 
The incorporation of carbons from labeled glucose into neutral lipids was 
significantly lower under hypoxia (0.1% O2) (4038 ± 43 dpm) than under 
normoxia (21% O2) (6904 ± 370 dpm) (Table 7).  However, the opposite was 
seen for the synthesis of neutral lipids from labeled glutamine under hypoxia. The 
incorporation of carbons from glutamine increased two folds (from 3154 ± 92 
dpm to 6258 ± 338 dpm).   
 
Hypoxia induced accumulation of triacylglycerols (TAG) in the neutral lipid 
fraction, which represented a significant amount of the lipid distribution (Figure 
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16).  TAG accumulation was seen in both total lipids (Figure 15), and the labeled 
lipids (Figure 17) derived from either glucose or glutamine. Additionally, hypoxia 
significantly reduced the incorporation of carbons into cholesterol derived from 
both labeled glucose and glutamine (Table 7, Figure 16). Incorporation of 
carbons from either labeled glucose or glutamine into PtdCho and EtnGpl was 
noticeably lower under hypoxia than normoxia (Figure 16).   
 
Acidic Lipids 
 
The influence of hypoxia on total acidic lipids in the VM-M3 cells is shown in 
Figure 18.  Similar to the neutral lipids, approximately 3000 dpm was spotted on 
the HPTLC plate for acidic lipids, and the calculated dpm in Table 8 is normalized 
to same number of cells. The incorporation of carbons from labeled glucose into 
acidic lipids was significantly lower under hypoxia (313 ± 8 dpm) than under 
normoxia (1568 ± 94 dpm) (Table 8).  Again, the opposite was seen for the 
synthesis of acidic lipids from labeled glutamine under hypoxia. The incorporation 
of carbons from glutamine increased not to the extent seen in neutral lipids but 
still significantly higher from 717 ± 13 dpm to 829 ± 38 dpm.  Hypoxia induced a 
reduction in the distribution of PtdSer, and BMP/PtdOH, but slightly increased 
PtdGro and PtdIns.  No changes were observed under hypoxia for Ptd2Gro using 
either labeled glucose or glutamine (Figure 19, Figure 20).  
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Overall, the incorporation glucose carbons into both neutral and acidic lipids were 
significantly less under hypoxia in comparison to normoxia.  Conversely, the 
incorporation of glutamine carbons into both neutral and acidic lipids was 
significantly higher under hypoxia (Figure 21). 
 
Gangliosides 
 
The influence of hypoxia on total gangliosides in the VM-M3 cells is shown in 
Figure 22.  For gangliosides approximately 2000 dpm was spotted on HPTLC 
plate.  The incorporation of carbons from labeled glucose into gangliosides was 
significantly lower under hypoxia (2115 ± 45 dpm) than under normoxia (3341 ± 
82 dpm) (Table 9).  There was no change in the incorporation of carbons from 
glutamine.  Hypoxia may have influenced the biosynthesis and distribution of 
either GM1 or GM2, but it is unclear which species was being modified due to 
poor separation (Figure 23). Future analysis using [14C] galactose could resolve 
this issue since galactose can be better incorporated into gangliosides.  	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Influence of hypoxia on lactate production from radiolabeled glucose or 
glutamine carbons 
 
Hypoxia enhanced the incorporation of glucose carbons into lactate.  Minimal 
lactate was derived from glutamine under hypoxia even though there was 
enhanced glutamine utilization for lipid biosynthesis (Figure 24 A, B).  The 
increase of glutamine utilization for lipid biosynthesis could be a compensatory 
response to the enhanced conversion of glucose into lactate. 
 
Hypoxia induced accumulation of triacylglycerols with increased saturated 
fatty acids  
 
Significant accumulation of TAG was seen in both total and labeled lipids for cells 
grew in hypoxia (Figure 15, Figure 17, Figure 25). Oil red O staining confirmed 
the accumulation of lipid droplets in the cells (Figure 26 C, D).  Re-oxygenation of 
the cells for 24 hrs reduced the TAG that had accumulated during the 24hrs 
incubation under hypoxia (Figure 25).  The respiratory inhibitor antimycin A (AA) 
also induced TAG accumulation (Figure 25) and the appearance of lipid droplets 
(Figure 26 E, F) similar to those seen under hypoxia.   Although both hypoxia and 
AA treatment induced TAG accumulation, the FA composition of TAG differed 
under the two conditions.  The TAG that accumulated under hypoxia migrated as  
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double bands on HPTLC plate, whereas the TAG that accumulated under AA 
treatment migrated only as a singlet (Figure 25). Longer and/or saturated FA 
migrated with higher Rf distance while shorter and/or unsaturated FA migrates 
with smaller Rf distance on HPTLC plate.  Further analysis using ESI tandem 
mass spectrometry further confirmed triglyceride accumulation in cells treated 
with hypoxia (Suppl. S1).  Data from ESI/MS also indicated a higher 
preponderance of shorter, saturated FA.  However, we were unable to identify 
the specific fatty acids that were elevated.  Henceforth, preparative HPTLC and 
GLC analysis were used to analyze the fatty acid composition of the lower 
(slower) and upper (faster) migrating bands of the TAG that accumulated under 
hypoxia.  FA accumulation was greater in the upper than in the lower TAG band 
(Table 10).  The proportion of saturated FA (C16:0, and C18:0) was greater in 
the upper TAG band than in the lower TAG band, whereas the proportion of 
unsaturated FA (C16:1) was less in the upper band than in the lower band, as 
indicated in Table 11.  Interestingly, the molar percent distribution of C18:1 was 
similar in the upper and lower bands.  
 
The relative distribution of the upper and lower TAG bands under hypoxia 
differed depending whether TAG was evaluated from the total lipids (Figure 15) 
or from the radiolabeled lipids (Figure 17).  In contrast to the higher intensity of 
the lower TAG band in comparison to the upper TAG band in the total lipids 
(Figure 15), the intensity of the lower bands were either similar or higher than the 
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upper bands in the TAG derived from radiolabeled lipids (Figure 17).  This finding 
suggested that saturated FA (derived from labeled glucose or labeled glutamine) 
were preferentially synthesized under hypoxia.  On the other hand, the TAG FA 
composition obtained from the total lipids contained more of the unsaturated 
species, as indicated by the higher intensity in the lower band of the doublet   
 
In vivo accumulation of triacylglycerol in subcutaneous implanted VM 
tumor 
 
VM-M3 tumor was implanted subcutaneously (s.c.) in VM mice for the duration of 
30 days.  A small tumor fragment from three sagital cross sections were obtained 
for triacylglycerol determination.   The outer section of the tumor comprised the 
least amount of TAG (1.5 ± 0.3 ug lipid/ 100 mg of dry tumor weight) in 
comparison to the middle region (2.1 ± 0.6 ug lipid/ 100 mg of dry tumor weight). 
The most inner region of the tumor accumulated the most TAG (3.5 ± 0.5 ug lipid/ 
100 mg of dry tumor weight) (Figure 27).     
 
Lipoprotein is required for VM-M3 cell viability and growth in the absence 
of FBS and under hypoxia 
 
Preliminary assessment of viability and growth was analyzed for VM-M3 cells 
growing in the presence or absence of FBS under hypoxia (Suppl. S2).  In the 
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presence of FBS and under hypoxia, cell viability and proliferation was higher 
compared to cells grown in the absence of FBS and under hypoxia. In addition, 
there was an increase in ceramide in cells growing in media without FBS and 
under hypoxia (Suppl. S3). The increase in ceramide has been implicated in a 
variety of physiological conditions including apoptosis and cell growth arrest.  
The supplementation of media with 5 mg/dL of lipoproteins, which primarily 
contain cholesteryl esters and cholesterol (data not shown), allowed cells to 
proliferate under hypoxia at a rate similar to cells growing in media containing 
10% FBS under hypoxia.  
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Discussion 
 
Interest is growing in the role of glucose and glutamine in cancer metabolism.  
These energy metabolites are thought to contribute to anabolic growth, and 
synthesis of ribonucleotides, nonessential amino acids, and NADPH. (Cairns et 
al. 2011, Yuneva 2008, Teicher et al. 2012, Vander Heiden 2011, Dang et al. 
2011, Rodriguez-Enriquez et al. 2009, Piva et al. 1998, Souba 1993, Moreadith 
et al. 1984, Lu et al. 2010, Meng et al. 2010).  Although prior studies have 
evaluated the contribution of glucose and glutamine to palmitate synthesis 
(C16:0) (DeBerardinis et al. 2007, Scott et al. 2011), no prior studies have 
examined the contribution of glucose and glutamine carbons to the total lipid 
profile in cancer cells.  In the current study, I conducted a full analysis of the lipid 
profile in a murine glioblastoma cell line using uniformly labeled [14C]-U-D-
glucose and [14C]-U-L-glutamine.  Both the total lipids and radiolabeled lipids 
were evaluated. 
 
Previous studies suggested that neoplastic cells synthesize all of their FA 
endogenously, even in the presence of an exogenous source of dietary lipids 
(Ookhtens et al. 1984). Various hypotheses posited that the dependency of 
cancer cells on lipogenesis was due to heightened expression of ACLY, ACC, 
and FASN lipids (Weljie et al. 2011, Menendez et al. 2007, Zhang et al. 2012, 
Vazquez-Martin et al. 2008, Hatzivassiliou et al. 2005).  There is accumulating 
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evidence, however, showing that tumor cells do not rely solely on endogenous 
FA biosynthesis for growth and proliferation.   
 
Our findings show that FBS, an exogenous lipid source, has a major impact on 
the incorporation of glucose and glutamine into lipids.  Lipids derived from 
exogenous sources can be as important for tumor cell growth as are those 
synthesized endogenously.  It was previously reported that mouse derived 
NeuGc containing gangliosides were found in U87 human glioma cell line, when 
grown as a xenograft in a SCID mouse and only minimally found when grown in 
vitro (Ecsedy et al. 1999).  The authors concluded that the NeuGc containing 
gangliosides were obtained from the host.  Recently, Normura’s group showed 
that multiple cancer cell lines could incorporate palmitate into phospholipids and 
signaling lipids (LPA, DAG, ceramide-1-P) (Louie et al. 2013).  In addition, 
Kuemmerle et al. described high expression of CD36 and LPL in vivo in multiple 
tumor cell types.  CD36 and LPL facilitate the uptake of extracellular FA into the 
cell (Kuemmerle et al. 2011).  In light of this confusion surrounding the 
contribution of endogenous and exogenous sources to cancer cells, it is 
important to delineate the contribution of exogenous FA sources to cancer cell 
lipid metabolism.  Furthermore, this confusion will require a re-examination and 
re-evaluation of the therapeutic strategies that target lipid biosynthesis (e.g. 
ACLY) for tumor management. 
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My data showed that glucose was the preferred substrate under normoxia for 
lipid biosynthesis in comparison to glutamine even though a significant amount of 
glucose was being converted to lactate.  Whereas in hypoxia, the utilization of 
glutamine into lipid biosynthesis is increased by 2 fold, nearing the level of 
glucose incorporation into lipids under normoxia. This is in agreement with 
previous reports showing enhanced utilization of glutamine for lipid biosynthesis 
under hypoxia. This may occur through the reductive carboxylation of glutamine 
derived α-ketoglutarate to citrate (Metallo et al. 2012, Filipp et al. 2012, Wise et 
al. 2011).   
 
There are also suggestions that glutamine can be converted to lactate through 
malic enzyme to also produce NADPH for lipid biosynthesis (DeBerardinis et al. 
2007).  However, we detected only minimal amounts of lactate being derived 
from glutamine.  My findings are consistent with the previous reports (Portais et 
al. 1996, Scott et al. 2011). Enhanced glutaminolysis in generating NADPH can 
still occur through the conversion of pyruvate to alanine through the 
transamination reaction.  However, Scott et al. have investigated the flux of [13C]-
U-D-glucose and [13C]-U-D-glutamine to lactate and alanine, and found only one 
of six melanoma samples analyzed produced an excess of alanine with minimal 
production of lactate (Scott et al. 2011).  Inherently, this could be a cell line 
specific phenomenon similar to that of Hela cells, where it is estimated that 13% 
of glutamine was converted to lactate (Reitzer et al. 1979).  Although glutamine is 
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a major metabolite for some cell lines including lung, ERB2+ breast or AKT 
transformed cancer cell lines (van den Heuvel et al. 2012, Fan et al. 2013, 
McGuirk et al. 2013), it is unclear if the lactate produced in these cells is derived 
largely from glutamine. It appears that glutamine carbons are not likely a major 
contributor to lactate production in tumor cells 
 
It is well documented that hypoxia can increase glycolysis (Semenza 2007, 
Semenza et al. 2001, Dang et al. 1999). However, the increase in triglyceride 
accumulation under hypoxia was unexpected.  Under hypoxia, FAs cannot be 
oxidatively metabolized and therefore accumulate as triacylglycerol (TAG).  TAG 
accumulation was present in both total lipid and labeled lipids derived from [14C]-
U-D-glucose and [14C]-U-D-glutamine when cells were grown under hypoxia.  
The diversion of FA into triglycerides under hypoxia is presumably an adaptation 
for cells to prevent toxic accumulation of free fatty acid.  Free fatty acids 
accumulation in non-adipogenic cell types can lead to lipotoxicity and cell death.  
Cytoplasmic palmitate can inhibit lipophagy and induce apoptosis (Liu et al. 
2013, Singh et al. 2012).  Indeed, palmitate represents approximately 50 mole 
percentage of FA in the TAG that was accumulated inside cells grown under 
hypoxia. The presence of TAG was also confirmed in the inner region of the 
tumor when VM-M3 was grown subcutaneously in the VM/Dk mice.  Ex vivo 1H-
NMR and in vivo 1H MRS revealed the presence of TAG in high-grade 
glioblastomas whereas it was absent in normal brain spectra, and high levels of 
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lipid droplets are associated with tumor aggressiveness in human brain tumors 
(Tugnoli et al. 2001, Opstad et al. 2007).   
 
Interestingly, there was no difference in the mole percent distribution of C18:1 
from the upper band to the lower band in the accumulated TAG under hypoxia.  
Since 18:1 is one of the predominant FA in glycerophospholipids, and is also the 
predominant FA in FBS (personal observation), it is possible that much of the 
C18:1 that was accumulated in the TAG was derived from the serum used in the 
media.  It also has been shown recently that Ras transformed cells scavenge 
predominantly C18:1 LPC to support growth (Kamphorst et al. 2013). 
 
In addition, hypoxia also reduced de novo synthesis of cholesterol.  Cholesterol, 
synthesized through the mevalonate pathway, similar to SCD-1, requires oxygen 
as the electron acceptor (Figure S4) (Bloch 1965, Nguyen et al. 2007, Summons 
et al. 2006).  Cholesterol was also observed to have the highest fold increase 
when serum was absent from the media.  My preliminary data also indicated that 
cholesterol supplementation in the form of lipoprotein is crucial for cellular 
viability and proliferation under hypoxia when FBS is absent from the media.  It 
can therefore be concluded that cholesterol becomes the essential component 
for tumor cells to proliferate both under normoxia and hypoxia and it can be 
acquired from the extracellular environment.  
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Hypoxia also influences the distribution of gangliosides.  Although due to poor 
HPTLC separation of the gangiosides, there was a consistent reduced intensity 
in the lower band of the GM1/GM2 gangliosides.  In addition, narrowing of the 
GD1a bands can also suggest an alteration in gangliosides.  Yin et al. have also 
found changes in mobility of gangliosides under hypoxia in Caco-2M colonic 
cancer cells and attributed it to the decrease of unsaturated very long chain fatty 
acid in the ceramide moiety.  Further studies using [14C] galactose will help 
resolve this issue, since it is readily incorporated into gangliosides 
   
In view of our findings and others showing that exogenous fatty acids can be 
obtained from the FBS (in vitro) or host serum (in vivo), it is unlikely that mono-
therapeutic targeting of FASN or ACLY alone will be an effective therapy for 
managing tumor cell growth.  A more effective approach would be to target 
availability of glucose and glutamine.  The restriction of these metabolites would 
not only inhibit synthesis of NADPH and nucleotides through the PPP pathway, 
but would also inhibit ATP production through glycolysis.  The inhibition of 
lipogenic processes provides an additional layer of protection of other metabolite 
contributions into lipid biosynthesis, i.e. acetoacetate. The involvement of lipin 
and diacylglycerol acyltransferase (DGAT) in triglyceride biosynthesis could be a 
potential target for solid tumors with hypoxic regions.  Hypoxia also enhances 
import of unsaturated FA and cholesterol due to the cell’s inability to synthesize 
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those molecules.  This property can also be further exploited for tumor 
management.  
 
My findings would also question the use of statins and cholesterol targeting as a 
cancer therapy, as the tumor cells will likely acquire cholesterol from the 
microenvironment thereby circumventing cholesterol-lowering drugs.  
Therapeutic approaches should be aimed at both the endogenous and the import 
pathways. The effectiveness of statins in vitro may be related to the inhibition of 
isoprenoid biosynthesis and protein modifications of Ras or Rho (prenylation, 
farnesylation, geranylgeranylation) in cancer, and not likely because of the 
inhibition of cholesterol biosynthesis (Bouterfa et al. 2000, Bifulco 2005, Zhong et 
al. 2005).  However, human clinical trials using statins as anticancer treatment 
were largely heterogeneous, inconclusive, and produced little evidence of a real 
efficacy as adjuvant therapy (Thibault et al. 1996, Larner et al. 1998, Kim et al. 
2001, Lersch et al. 2004).  My results can provide insight on these issues. 	  
In conclusion, cancer therapeutic interventions that target lipid biosynthesis must 
take into consideration not only the endogenous pathway, but also the import 
pathway of acquiring exogenous lipids. 	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Summary 
 
Overall, my findings indicated that the murine VM-M3 glioblastoma cell line could 
acquire lipids from the extracellular environment.  This is in agreement with the 
original work done by Medes et. al in the 1950’s and is in opposition to the 
popular view of lipogenesis in cancer, which considers lipid synthesis in cancer 
cells as self sufficient. In other words, cancer cells preferentially synthesize their 
own fatty acids even in the presence of exogenous lipids. The data shown here 
indicate that the VM-M3 glioblastoma cells could acquire lipids, especially 
cholesterol, from the external environment for growth and proliferation, 
particularly under hypoxia where a limited amount of cholesterol is synthesized.   
 
While glucose carbons are preferentially used and incorporated into lipids under 
normoxia, glutamine carbons are preferentially incorporated into lipids under 
hypoxia.  This is due to the enhanced conversion of glucose into lactate rather 
than entering the TCA cycle.  The enhanced incorporation of glutamine carbons 
into lipids under hypoxia corroborates other methods of analysis using 13C 
labeled substrates in human glioblastoma and melanoma cell lines. 
 
Current work described here also provides a better overview of endogenously 
synthesized lipids including glycerophospholipid, cholesterols, triacylglycerols, 
and gangliosides derived from  [14C]-U-D-glucose and [14C]-U-D-glutamine. The 
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unnatural cell culture environment can also significantly influence the amounts 
and types of lipids synthesized from glucose and glutamine carbons.   
 
In addition, in the model of murine glioblastoma that was examined in this study, 
lactate is largely derived from glucose and not from glutamine. A brief summary 
depicting the relative incorporation of glucose and glutamine into lipids and 
lactate is presented in Figure 28 A, B.  
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Tables and Figures 	  
Figure 3. Glucose and glutamine metabolism converge at citrate for lipid 
synthesis 
Glucose and glutamine metabolism converge at citrate for lipid synthesis. 
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Figure	  3.	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Table 1.  Influence of FBS on total neutral lipids molar percent distribution in VM-
M3 cells 
	  	  
FBSb
Neutral Lipidsc
TAG 6.1 ± 0.9 7.3 ± 0.6
C 27.8 ± 2.1 26.5 ± 0.9
Cer 6.5 ± 0.7 7.3 ± 0.2
EtnGpl 21.8 ± 0.4 20.6 ± 0.2
PtdCho 21.8 ± 1.4 21.3 ± 0.7
CerPCho 9.6 ± 1.1 10.4 ± 0.8
LysoPtdCho trace trace
+" #"
Table)1.)Influence)of)FBS)on)total)neutral)lipids)molar)percent)
distribution)in)VM;M3)cellsa
a  Values represent  percentage distribution generated from 
scanning of HPTLC plate similar to that seen in Figure 3, and 
are expressed as means ± SEM of 4 independent samples.  
Two samples from both radiolabled glucose and glutamine 
were combined in calculating total lipid distribution since no 
changes were observed in the  lipid distribution in either the 
presence or absence of FBS.
b  Fetal bovine serum at 10% of media.
c The amount of lipid spotted was equivalent to 3 x 106 cells.  
Abbreviations for lipids are as followed: TAG, triacylglycerol; C, 
cholesterol; Cer, ceramide; EtnGpl, phosphatidylethanolamine; 
PtdCho, phosphatidylcholine; CerPCho, sphingomyelin; 
LysoPtdCho, lyso-phosphatidylcholine. 	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Figure 4. High performance thin-layer chromatography (HPTLC) analysis of total 
neutral (non-labeled and labeled) lipids in VM-M3 tumor cell line grown in DMEM 
esence or absence of FBS 
High performance thin-layer chromatography (HPTLC) analysis of total neutral 
(non-labeled and labeled) lipids in VM-M3 tumor cell line grown in DMEM in the 
presence or absence of FBS.  The amount of lipid spotted was equivalent to 3 x 
106 cells.  The abbreviations used are as indicated: lysoPtdCho, 
lysophosphatidylcholine; CerPCho, sphingomyelin; PtdCho, phosphatidylcholine; 
EtnGpl, phosphatidylethanolamine; Cer, ceramide; C, cholesterol; TAG, 
triglycerides; MB, mouse brain; STD, standard.  The plates were developed to 
the initial solvent front (SF) with chloroform: methanol: acetic acid: formic acid: 
water (70:30:12:4:2 by volume) and to the top with hexanes: diisopropyl ether: 
acetic acid (65:35:2 by volume).  Lipids were visualized by charring with 3% 
cupric acetate in 8% phosphoric acid solution, followed by heating in an oven at 
1650C for 7 min.  Since an equal number of cells was spotted on the HPTLC 
plate, there were no differences in the distribution of the total lipids in experiment 
using either labeled glucose or labeled glutamine.  Hence, only representative 
samples were presented.   
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Figure 4. 
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Table 2. Influence of FBS on incorporation of carbons from [14C] glucose and 
[14C] glutamine into neutral lipids in VM-M3 
 
FBS + - + - 
Neutral Lipidsb
TAG 228 ± 5 76 ± 2 112 ± 17 138 ± 7
C 400 ± 31 1127 ± 126 254 ± 3 575 ± 22
Cer 268 ± 31 251 ± 12 163 ± 4 264 ± 17
EtnGpl 1045 ± 87 2008 ± 276 427 ± 42 920 ± 9
PtdCho 2002 ± 156 3604 ± 405 900 ± 50 1647 ± 16
CerPCho 542 ± 47 686 ± 67 329 ± 28 520 ± 4
LysoPtdCho 112 ± 2 55 ± 14 88 ± 7 125 ± 12
Total DPM 5075 ± 92 8100 ± 931 2557 ± 131 4574 ± 44
Abbreviations for lipids are as indicated in Table 1.
Table 2.  Influence of FBS on incorporation of carbons from [14C] glucose and [14C] 
glutamine  into neutral lipids in VM-M3 cellsa 
[14C] Glucose [14C] Glutamine
Values represent  calculated disintegration per minute (dpm),  expressed as means ±  
interquartile range (IQR) of two independent samples.  Individual lipids dpm are 
calculated from the percent distribution (as seen in figure 4) x total dpm. 
a    Fetal bovine serum at 10% of media.  Cells were grown in either the presence of 
absence of FBS with either [14C] glucose and [14C] glutamine for 48hrs as described in 
the methods section.                                                               
b  The amount of lipid spotted is as described in Table 1.    
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Figure 5.  Influence of FBS on radiolabeled neutral lipids molar percent 
distribution 
Influence of FBS on radiolabeled neutral lipids molar percent distribution.  Values 
represent mole percent distribtion and expressed as the means ± IQR  of two 
independent samples as represented in Figure 6.  Cells were grown in either the 
presence or absence of FBS with either [14C]-U-D-glucose and [14C]-U-D-
glutamine for 48 hrs. as described in the Method section.  Abbreviations are as 
indicated in Figure 4.  
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Figure 5. 	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Figure 6.  HPTLC analysis of endogenously synthesized (radiolabeled) neutral 
lipids in VM-M3 tumor cell line grown in DMEM in the presence or absence of 
FBS using uniformly labeled [14C] glucose or [14C] glutamine 
HPTLC analysis of endogenously synthesized (radiolabeled) neutral lipids in VM-
M3 tumor cell line grown in DMEM in the presence or absence of FBS using 
uniformly labeled [14C] glucose or [14C] glutamine. The amount of lipid spotted 
was equivalent to 3 x 106 cells.  Radiolabeled lipids were visualized with 
PhosphoImager.  Abbreviations are as indicated in Figure 4. 
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Figure 6. 
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Table 3 Influence of FBS on total acidic lipids molar percent distribution in VM-
M3 cells 
FBSb
Acidic Lipidsc
Ptd2Gro 9.2 ± 0.7 10.5 ± 1.0
BMP/PtdOH 7.8 ± 0.5 8.8 ± 0.7
PtdGro 3.4 ± 0.3 5.0 ± 0.9
PtdSer 38.0 ± 1.1 37.3 ± 0.9
PtdIns 32.2 ± 1.1 31.7 ± 1.9
Abbreviations for lipids are as followed: Ptd2Gro, cardiolipin; 
PtdOH, phosphatidic acid; BMP, 
bis(monoacylglycero)phosphate; PtdGro, phosphatidylglycerol; 
PtdSer, phosphatidylserine; PtdIns, phosphatidylinositol
+" #"
b  Fetal bovine serum at 10% of media.
c The amount of lipid spotted was equivalent to 6 x 106 cells.  
Table)3.)Influence)of)FBS)on)total)acidic)lipids)molar)percent)
distribution)in)VM;M3)cellsa
a  Values represent  percentage distribution generated from 
scanning of HPTLC plate similar to that seen in Figure 6, and 
are expressed as means ± SEM of 4 independent samples.  
Two samples from both radiolabled glucose and glutamine 
were combined in calculating total lipid distribution since no 
changes were observed in the  lipid distribution in either the 
presence or absence of FBS.
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Figure 7. HPTLC analysis of total acidic (non-labeled and labeled) lipids in VM-
M3 tumor cell line grown in DMEM presence or absence of FBS 
 
HPTLC analysis of total acidic (non-labeled and labeled) lipids in VM-M3 tumor 
cell line grown in DMEM in the presence or absence of FBS.  The amount of lipid 
spotted was equivalent to 6 x 106 cells.  The abbreviations used are as indicated: 
PtdIns, phosphatidylinositol; PtdSer, phosphatidylserine; PtdGro, 
phosphatidylglycerol; PtdOH, phosphatidic acid; BMP, 
bis(monoacylglycero)phosphate; Ptd2Gro , cardiolipin; MB, mouse brain; STD, 
standard. Developing solvents, and lipid visualization is as indicated in Figure 4.  
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Figure 7. 
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Table 4. Influence of FBS on incorporation of carbons from [14C] glucose and 
[14C] glutamine into acidic lipids in VM-M3 cells 
FBS + - + - 
Acidic Lipidsb
Ptd2Gro 271 ± 26 368 ± 19 167 ± 10 283 ± 7
BMP/PtdOH 350 ± 15 593 ± 10 200 ± 14 378 ± 1
PtdGro 256 ± 16 489 ± 9 159 ± 16 268 ± 3
PtdSer 959 ± 92 1352 ± 140 505 ± 2 923 ± 73
PtdIns 1276 ± 150 1762 ± 213 519 ± 20 1094 ± 67
Total DPM 3247 ± 301 4721 ± 337 1667 ± 73 3077 ± 128
Abbreviations for lipids are as indicated in Table 3.
Table 4.  Influence of FBS on incorporation of carbons from [14C] glucose and [14C] 
glutamine  into acidic lipids in VM-M3 cellsa 
[14C] Glucose [14C] Glutamine
Values represent  calculated disintegration per minute (dpm),  expressed as means ±  
interquartile range (IQR) of two independent samples.  Individual lipids dpm are 
calculated from the percent distribution (as seen in figure 7) x total dpm. 
a    Fetal bovine serum at 10% of media.  Cells were grown in either the presence of 
absence of FBS with either [14C] glucose and [14C] glutamine for 48hrs as described in 
the methods section.                                                               
b  The amount of lipid spotted is as described in Table 3.    
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Figure 8. Influence of FBS on radiolabeled acidic lipids molar percent distribution 
Influence of FBS on radiolabeled acidic lipids molar percent distribution.  Values 
represent mole percent distribtion and expressed as the means ± IQR  of two 
independent samples as represented in Figure 9.  Cells were grown in either the 
presence or absence of FBS with either [14C]-U-D-glucose and [14C]-U-D-
glutamine for 48hrs as described in the Method section.  Abbreviations are as 
indicated in Figure 7.  
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Figure 8. 
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Figure 9. HPTLC analysis of endogenously synthesized (radiolabeled) acidic 
lipids in VM-M3 tumor cell line grown in DMEM in the presence or absence of 
FBS using uniformly labeled [14C] glucose or [14C] glutamine 
 
HPTLC analysis of endogenously synthesized (radiolabeled) acidic lipids in VM-
M3 tumor cell line grown in DMEM in the presence or absence of FBS using 
uniformly labeled [14C] glucose or [14C] glutamine. The amount of lipid spotted 
was equivalent to 6 x 106 cells.  Radiolabeled lipids were visualized with 
PhosphoImager.  Abbreviations are as indicated in Figure 7. 
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Figure 9. 
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Figure 10. The influence of FBS on incorporation of carbons from [14C] glucose or 
[14C] glutamine on total dpm from neutral and acidic lipids 
The influence of FBS on incorporation of carbons from [14C] glucose or [14C] 
glutamine on total dpm from neutral and acidic lipids.  The calculated total dpm is 
the sum of the dpm of the neutral lipids (Table 2) plus dpm of the acidic lipids 
(Table 4).  Values represent as mean ± IQR  of two independent samples.   
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Figure 10. 
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Table 5. Influence of FBS on total ganglioside molar percent distribution in VM-
M3 cells 
FBSb
Gangliosidesc
GM2 25.4 ± 0.6 24.4 ± 0.5
GM1 28.2 ± 0.5 28.5 ± 0.4
GD1a 46.1 ± 1.1 47.1 ± 1.2
c The amount of lipid spotted was equivalent to 15 x 106 cells.  
The individual gangliosides were labeled according to the 
nomenclature system of Svennerholm.
Table)5.)Influence)of)FBS)on)total)ganglioside)molar)percent)
distribution)in)VM<M3)cellsa
+" #"
b  Fetal bovine serum at 10% of media.
a  Values represent  percentage distribution generated from 
scanning of HPTLC plate similar to that seen in Figure 10, and 
are expressed as means ± SEM of 4 independent samples.  
Two samples from both radiolabled glucose and glutamine 
were combined in calculating total lipid distribution since no 
changes were observed in the  lipid distribution in either the 
presence or absence of FBS.
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Figure 11. HPTLC analysis of endogenously synthesized (radiolabeled) acidic 
lipids in VM-M3 tumor cell line grown in DMEM in the presence or absence of 
FBS using uniformly labeled [14C] glucose or [14C] glutamine 
 
HPTLC analysis of total gangliosides (non-labeled and labeled) in VM-M3 tumor 
cell line grown in DMEM in the presence or absence of FBS.  The amount of lipid 
spotted was equivalent to 15 x 106 cells. The plate was developed with a single 
solvent system with chloroform: methanol: 0.02% (55:45:10 by volume).  Lipids 
were visualized by spraying with resorcinol-HCL reagent, followed by heating at 
1000C for 10 min.  The individual gangliosides were labeled according to the 
nomenclature system of Svennerholm.  MB indicates mouse brain.   
	   68	  
Figure 11 
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Table 6. Influence of FBS on incorporation of carbons from [14C] glucose and 
[14C] glutamine into ganglioside in VM-M3 cells 
FBS + - + - 
Gangliosidesb
GM2 699 ± 138 632 ± 25 491 ± 8 514 ± 23
GM1 927 ± 229 693 ± 33 603 ± 18 569 ± 30 
GD1a 1188 ± 247 1036 ± 141 557 ± 24 517 ± 47
Total DPM 2815 ± 615 2360 ± 240 1650 ± 168 1600 ± 100
The individual gangliosides were labeled according to the nomenclature of Svennerholm.
Abbreviations for lipids are as indicated in Table 3.
Table 6.  Influence of FBS on incorporation of carbons from [14C] glucose and [14C] 
glutamine into ganglioside in VM-M3 cellsa 
[14C] Glucose [14C] Glutamine
Values represent  calculated disintegration per minute (dpm),  expressed as means ±  
interquartile range (IQR) of two independent samples.  Individual lipids dpm are 
calculated from the percent distribution (as seen in figure 11) x total dpm. 
a    Fetal bovine serum at 10% of media.  Cells were grown in either the presence of 
absence of FBS with either [14C] glucose and [14C] glutamine for 48hrs as described in 
the methods section.                                                               
b  The amount of lipid spotted is as described in Table 5.    
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Figure 12. Influence of FBS on radiolabeled ganglioside molar percent 
distribution 
 
Influence of FBS on radiolabeled ganglioside molar percent distribution.  Values 
represent mole percent distribtion and expressed as the means ± IQR  of two 
independent samples as represented in Figure 13.  Cells were grown in either 
the presence or absence of FBS with either [14C]-U-D-glucose and [14C]-U-D-
glutamine for 48hrs as described in the Method section.  The individual 
gangliosides were labeled according to the nomenclature system of 
Svennerholm.   
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Figure 12. 
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Figure 13. HPTLC analysis of endogenously synthesized (radiolabeled) 
gangliosides in VM-M3 tumor cell line grown in DMEM in the presence or 
absence of FBS using uniformly labeled [14C] glucose or [14C] glutamine 
HPTLC analysis of endogenously synthesized (radiolabeled) gangliosides in VM-
M3 tumor cell line grown in DMEM in the presence or absence of FBS using 
uniformly labeled [14C] glucose or [14C] glutamine. The amount of lipid spotted 
was equivalent to 15 x 106 cells.  Radiolabeled lipids were visualized with 
PhosphoImager.  The individual gangliosides were labeled according to the 
nomenclature system of Svennerholm.   
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Figure 13. 
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Figure 14. HPTLC analysis of lactate derived from the media of VM-M3 grown in 
DMEM in the presence or absence of FBS using uniformly labeled [14C] glucose 
and [14C] glutamine 
HPTLC analysis of lactate derived from the media of VM-M3 grown in DMEM in 
the presence or absence of FBS using uniformly labeled [14C] glucose and [14C] 
glutamine.  Equal amount of 250ul of the media was spotted (a) and data 
analysis was normalized to equal number of cells (b).  The plate was developed 
in a single ascending solvent with butanol: acetic acid: water (50:11:25 by 
volume) for 5 hrs.  Values shown in (b) represent two independent samples and 
are expressed as means ± IQR. 
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Figure 14. 
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Figure 15. HPTLC analysis of total neutral (non-labeled and labeled) lipids in VM-
M3 tumor cell line grown under the influence of oxygen 
HPTLC analysis of total neutral (non-labeled and labeled) lipids in VM-M3 tumor 
cell line grown under the influence of oxygen. The amount of lipid spotted was 
equivalent to 3000 dpm.  Same amount of dpm were spotted here on HPTLC 
plate to show qualitative changes in lipids under the influence of hypoxia. This 
corresponded to different number of cells spotted as represented by the different 
intensity of the bands in total lipids.  Developing solvents, and lipid visualization 
is as indicated in Figure 4. The abbreviations used are as indicated in Figure 4.  
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Figure 15. 
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Table 7 Influence of O2 on incorporation of carbons from [14C] glucose and [14C] 
glutamine into neutral lipids in VM-M3 cells 
 
 
  
O2 21% 0.1% 21% 0.1%
Neutral Lipidsb
TAG upper N.D. 332 ± 13 N.D. 827 ± 84
TAG lower Trace 306 ± 21 Trace 828 ± 28
C 822 ± 82 262 ± 14 525 ± 24 450 ± 31
Cer 385 ± 5 174 ± 7 201 ± 6 344 ± 24
EtnGpl 967± 40 324 ± 5 530 ± 26 550 ± 25
PtdCho 3171 ± 219 1761 ± 49 1822 ± 78 1962 ± 113
CerPCho 661 ± 40 226 ± 24 454 ± 19 476 ± 22
LysoPtdCho 330 ± 45 148 ± 16 182 ± 4 217 ± 16
Total DPM 6904 ± 370 4038 ± 43 * 3154 ± 92  6258 ± 338 *
Abbreviations of lipids are as indicated in Table 1.
N.D -  None detected. 
Table 7. Influence of O2 on incorporation of carbons from [14C]  glucose and 
[14C] glutamine into neutral lipids in VM-M3 cellsa
[14C] Glucose [14C] Glutamine
Calculated dpm were normalized to same number of cells, and expressed as means 
± SEM of three independent samples.  Individual lipids dpm are calculated from the 
percent distribution (as seen in figure 15) x total dpm.  * indicates significant 
differences from 21% O2 at p < 0.02.                                                 
b  The amount of lipid spotted was equivalent to 3000 dpm.
a  Cells were grown in DMEM with 10% FBS in the presence of 21% O2 or 0.1% O2 
with either [14C] glucose and [14C] glutamine for 48hrs.   
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Figure 16. Influence of hypoxia on radiolabeled neutral lipids molar percent 
distribution 
Influence of hypoxia on radiolabeled neutral lipids molar percent distribution.  
Values represent mole percent distribtion of lipids as represented in Figure 17 
and expressed as the means ± SEM  of three independent samples.  Mole 
percent distribution for upper TAG and lower TAG (as seen in Figure 17) is 
combined to represent one nominal value.  Cells were grown in either normoxia 
(21% O2) or hypoxia (0.1% O2)  with either [14C]-U-D-glucose and [14C]-U-D-
glutamine for 48hrs as described in the Method section.  Asterisk indicates 
significant difference from 21% O2 at p < 0.02.  Abbreviations are as indicated in 
Figure 4.  
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Figure 16. 
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Figure 17. HPTLC analysis of endogenously synthesized (radiolabeled) neutral 
lipids in VM-M3 tumor cell line grown in either normoxia (21% O2) or hypoxia 
(0.1% O2)   using uniformly labeled [14C] glucose or [14C] glutamine 
HPTLC analysis of endogenously synthesized (radiolabeled) neutral lipids in VM-
M3 tumor cell line grown in either normoxia (21% O2) or hypoxia (0.1% O2)   
using uniformly labeled [14C] glucose or [14C] glutamine. The amount of lipid 
spotted was equivalent to 3000 dpm.  Radiolabeled lipids were visualized with 
PhosphoImager. Abbreviations are as indicated in Figure 4. 
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Figure 17. 
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Figure 18. HPTLC analysis of total acidic (non-labeled and labeled) lipids in VM-
M3 tumor cell line grown under the influence of oxygen 
 
HPTLC analysis of total acidic (non-labeled and labeled) lipids in VM-M3 tumor 
cell line grown under the influence of oxygen. The amount of lipid spotted was 
equivalent to 3000 dpm.  Same amount of dpm were spotted here on HPTLC 
plate to show qualitative changes in lipids under the influence of hypoxia. This 
corresponded to different number of cells spotted as represented by the different 
intensity of the bands in total lipids.  Developing solvents, and lipid visualization 
is as indicated in Figure 7. The abbreviations used are as indicated in Figure 7.  
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Figure 18. 
 
 
 
 
 
 
 
 
 
 
 
  
21% 0.1% 21% 0.1% 
STD 
SF 
Origin 
Acidic Lipids 
PtdIns 
PtdSer 
PtdGro 
BMP/PtdOH  
Ptd2Gro 
Derived from 
14C glucose 
Derived from 
14C glutamine 
O2 
	  	  
85	  
Table 8. Influence of O2 on incorporation of carbons from [14C] glucose and [14C] 
glutamine into acidic lipids in VM-M3 cells  
 
  
O2 21% 0.1% 21% 0.1%
Acidic Lipidsb
Ptd2Gro 260 ± 33 53 ± 4 119 ± 3 135 ± 3
PtdOH/BMP 291 ± 27 52 ± 1 143 ± 8 127 ± 11
PtdGro 123 ± 3 37 ± 2 52 ± 3 85 ± 2
PtdSer 444 ± 16 73 ± 1 219 ± 3 222 ± 20
PtdIns 450 ± 29 97 ± 2 185 ± 7 260 ± 9
Total DPM 1568 ± 94 313 ± 8 * 717 ± 13 829 ± 38 *
b  The amount of lipid spotted was equivalent to 3000 dpm 
Abbreviations of lipids are as indicated in Table 3.
Table 8. Influence of O2 on incorporation of carbons from [14C]  glucose and 
[14C] glutamine into acidic lipids in VM-M3 cellsa
[14C] Glucose [14C] Glutamine
Calculated dpm were normalized to same number of cells, and expressed as means 
± SEM of three independent samples.  Individual lipids dpm are calculated from the 
percent distribution (as seen in figure 18) x total dpm.  * indicates significant 
differences from 21% O2 at p < 0.02.                                                 
a  Cells were grown in DMEM with 10% FBS in the presence of 21% O2 or 0.1% O2 
with either [14C] glucose and [14C] glutamine for 48hrs.   
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Figure 19.Influence of hypoxia on radiolabeled acidic lipids molar percent 
distribution 
 
Influence of hypoxia on radiolabeled acidic lipids molar percent distribution.  
Values represent mole percent distribtion of lipids as represented in Figure 20 
and expressed as the means ± SEM  of three independent samples.  Cells were 
grown in either normoxia (21% O2) or hypoxia (0.1% O2)  with either [14C]-U-D-
glucose and [14C]-U-D-glutamine for 48hrs as described in the Method section.  .  
Asterisk indicates significant difference from 21% O2 at p < 0.02.  Abbreviations 
are as indicated in Figure 7.  
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Figure 19. 
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Figure 20. HPTLC analysis of endogenously synthesized (radiolabeled) acidic 
lipids in VM-M3 tumor cell line grown in either normoxia (21% O2) or hypoxia 
(0.1% O2)   using uniformly labeled [14C] glucose or [14C] glutamine 
 
HPTLC analysis of endogenously synthesized (radiolabeled) acidic lipids in VM-
M3 tumor cell line grown in either normoxia (21% O2) or hypoxia (0.1% O2)   
using uniformly labeled [14C] glucose or [14C] glutamine. The amount of lipid 
spotted was equivalent to 3000 dpm.  Radiolabeled lipids were visualized with 
PhosphoImager. Abbreviations are as indicated in Figure 4. 
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Figure 20. 
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 Figure 21. The influence of hypoxia on incorporation of carbons from [14C] 
glucose or [14C] glutamine on total dpm from neutral and acidic lipids 
 
The influence of hypoxia on incorporation of carbons from [14C] glucose or [14C] 
glutamine on total dpm from neutral and acidic lipids.  The calculated total dpm is 
the sum of the dpm of the neutral lipids (Table 7) plus dpm of the acidic lipids 
(Table 8).  Values represent as mean ± SEM  of three independent samples.  
Asterisk indicates significant difference from 21% O2 at p < 0.01.   
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Figure 22. HPTLC analysis of total gangliosides (non-labeled and labeled) in VM-
M3 tumor cell line grown under the influence of oxygen 
	  
HPTLC analysis of total gangliosides (non-labeled and labeled) in VM-M3 tumor 
cell line grown under the influence of oxygen. The amount of lipid spotted was 
equivalent to 2000 dpm. Developing solvents, and lipid visualization is as 
indicated in Figure 11. The individual gangliosides were labeled according to the 
nomenclature system of Svennerholm.  MB indicates mouse brain.   
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Figure 22. 
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Table 9. Influence of O2 on incorporation of carbons from [14C] glucose and 
[14C] glutamine into gangliosides in VM-M3 cells  
 
  
O2 21% 0.1% 21% 0.1%
Gangliosidesb
GM1/GM2 1489 ± 94 958 ± 16 1047 ± 10 1187 ± 32
GD1a 1836 ± 21 1158 ± 31 1038 ± 28 1258 ± 6
Total DPM 3341 ± 82 2115 ± 45 * 2086 ± 56 2445 ± 52 
Calculated dpm were normalized to same number of cells, and expressed as means 
± SEM of three independent samples.  Individual lipids dpm are calculated from the 
percent distribution x total dpm.  * indicates significant differences from 21% O2 at p 
< 0.02.                                                 
a  Cells were grown in DMEM with 10% FBS in the presence of 21% O2 or 0.1% O2 
with either [14C] glucose and [14C] glutamine for 48hrs.   
b  The amount of lipid spotted was equivalent to 2000 dpm 
Table 9. Influence of O2 on incorporation of carbons from [14C]  glucose and 
[14C] glutamine into gangliosides in VM-M3 cellsa
[14C] Glucose [14C] Glutamine
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Figure 23. HPTLC analysis of endogenously synthesized (radiolabeled) 
gangliosides in VM-M3 tumor cell line grown in either normoxia (21% O2) or 
hypoxia (0.1% O2) using uniformly labeled [14C] glucose or [14C] glutamine 
	  
HPTLC analysis of endogenously synthesized (radiolabeled) gangliosides in VM-
M3 tumor cell line grown in either normoxia (21% O2) or hypoxia (0.1% O2)   
using uniformly labeled [14C] glucose or [14C] glutamine. The amount of lipid 
spotted was equivalent to 2000 dpm.  Radiolabeled lipids were visualized with 
PhosphoImager.  The individual gangliosides were labeled according to the 
nomenclature system of Svennerholm. 	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Figure 23. 
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Figure 24. HPTLC analysis of lactate derived from the media of VM-M3 grown in 
DMEM in either normoxia (21% O2) or hypoxia (0.1% O2) using uniformly labeled 
[14C] glucose and [14C] glutamine 
	  
HPTLC analysis of lactate derived from the media of VM-M3 grown in DMEM in 
either normoxia (21% O2) or hypoxia (0.1% O2) using uniformly labeled [14C] 
glucose and [14C] glutamine.  Equal amount of 250 ul of the media was spotted 
(a) and data analysis was normalized to equal number of cells (b).  Developing 
solvents is as indicated in Figure 14.  Values shown in (b) represent three 
independent samples and are expressed as means ± SEM.  Asterisk indicates 
significant difference from 21% O2 at p < 0.01. 	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Figure 24. 
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Figure 25. HPTLC analysis of triacylglycerol accumulation under the influence of 
hypoxia or ETC inhibitor antimycin A (AA) 
 
 
HPTLC analysis of triacylglycerol accumulation under the influence of hypoxia or 
ETC inhibitor antimycin A (AA).  Neutral lipids were separated according to the 
Material and Methods.  The amount of lipids spotted was equivalent to 1 x 106 
cells.  The abbreviations used are as indicated: PL, phospholipids; C, cholesterol; 
TAG, triacylglycerol.  The plate was developed in a single solvent system with 
hexanes: diethyl ether: acetic acid (70:30:1).  Cells were either grown in 
normoxia (21% O2), anoxia (0.1% O2) for 24 hrs, reoxygenated at 21% O2 for 24 
hrs, or 0.1 uM antimycin A (AA). 
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Figure 25.	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Figure 26. Oil Red O staining of triacylglyerol 
 
 
Oil Red O staining of triacylglycerol in normoxia (B), anoxia, (D), and 0.1% 
antimycin A (F) and the corresponding differential interference contrast (DIC) for 
normoxia (A), anoxia (C), and 0.1 µM antimycin A (E).  Magnification is 63X.  
Three independent samples were analyzed per group. 
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Figure 26. 
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Table 10. Influence of hypoxia (0.1% O2) on the fatty acid content of 
triacylglycerol  
Fatty acids
14:0 0.73 ± 0.05 0.14 ± 0.02 *
16:0 3.66 ± 0.18 1.20 ± 0.11 *
16:1 1.36 ± 0.15 0.24 ± 0.03 *
18:0 0.24 ± 0.02 0.13 ± 0.00 *
18:1 2.40 ± 0.16 0.68 ± 0.04 *
C22 + 0.25 ± 0.03 0.11 ± 0.00 *
Values represent fatty acid content  ± SEM from 3 independent samples using C17:0 
as the internal standard.   * indicates that the value in the upper band is significantly 
different from the value in the lower band at p < 0.02, as determined by ANOVA.
Fractions represent lower and upper triacylglyerol band  similar to that seen in 
Figure 25.  Fatty acid analysis was carried out using preparative TLC as mentioned 
in the Materials and Methods.
Table 10. Influence of hypoxia (0.1% O2) on the fatty acid content of 
triacylglycerol (ng lipid/106 cells)
Fractions
Lower band Upper band
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Table 11. Influence of hypoxia (0.1% O2) on the relative molar percent 
distribution of triacylglycerol fatty acids 
Fatty acids
14:0 8.4 ± 1.0 5.7 ± 0.6 *
16:0 42.3 ± 0.3 47.8 ± 0.5 *
16:1 15.7 ± 1.3 9.7 ± 0.7 *
18:0 2.8 ± 0.3 5.4 ± 0.4 *
18:1 27.7 ± 0.4 27.4 ± 1.0
C22 + 2.9 ± 0.4 4.3 ± 0.4 *
SFA/UFA 1.2 ± 0.3 1.6 ± 0.1 *
Table 11.  Influence of hypoxia (0.1% O2) on the relative molar percent 
distribution of  triacylglycerol fatty acids
Fractions
Lower band Upper band
Fractions represent lower and upper triacylglyerol band  similar to that seen in 
Figure 25.  Fatty acid analysis was carried out using preparative TLC as mentioned 
in the Materials and Methods.
Values represent mean mole percentage distribution of fatty acid ± SEM from 3 
independent samples.  * indicates that the value in the upper band is significantly 
different from the value in the lower band at p < 0.02, as determined by ANOVA.
SFA - saturated fatty acid; UFA - unsaturated fatty acid  
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Figure 27. In vivo accumulation of triacylglycerol in subcutaneous implanted VM 
tumor 
In vivo accumulation of triacylglycerol in subcutaneous implanted VM tumor.  VM-
M3 tumor was implanted subcutaneously (s.c) in VM mice for the duration of 30 
days.  A small tumor fragment from three sagital cross sections were obtained for 
triacylglycerol determination.  Values represent µg lipid / 100 µg of dry tumor 
weight. 	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Figure 27. 
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Figure 28. Summary of the relative incorporation of carbons from glucose and 
glutamine into lipid biosynthesis and lactate production in either normoxia or 
hypoxia 
Summary of the relative incorporation of carbons from glucose and glutamine 
into lipid biosynthesis and lactate production in either normoxia or hypoxia. 
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Figure 28. 
A.	  	  
 
B. 
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Supplemetary Figures 
 
 
Figure S1.  ESI tandem mass spectrometry of triacylglyerol in either normoxia 
(21% O2) or anoxia (0.1% O2) for 24 hrs 
ESI tandem mass spectrometry of triacylglycerol mass content of VM-M3 cells 
grown in either normoxia (21% O2) or anoxia (0.1% O2) for 24 hrs. 	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Figure S1. 
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Figure S2.  Lipoprotein is required for cell growth under hypoxia and in the 
absence of FBS. 
 
Lipoprotein is required for cell viability and growth under hypoxia and in the 
absence of FBS. Cell viability and growth were assessed by trypan blue 
exclusion dye test.  Cells were seeded at 200 (x100) cells and grew under 0.1% 
O2 for 24 hrs in media containing no FBS, no FBS + 5 mg/dL lipoprotein, or 10% 
FBS.  
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Figure S2. 
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Figure S3.  Ceramide accumulation in cells growing under hypoxia and in the 
absence of FBS 
Ceramide accumulation in cells growing under hypoxia and in the absence of 
FBS.  Neutral lipids were separated according to the Material and Methods.  The 
amount of lipids spotted was equivalent to 1 x 106 cells.  The abbreviations used 
are as indicated in Table 1.  Cells were either grown in normoxia (21% O2) or 
hypoxia (0.1% O2) and with FBS or no FBS for 24 hrs.  
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Figure S3. 
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Figure S4.  Schematic representation of cholesterol biosynthesis 
	  
Schematic representation of cholesterol biosynthesis.  11 molecules of oxygen 
are required to synthesize a single molecule of cholesterol. 	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Figure	  S4.	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CHAPTER THREE 	  
Autosomal dominant inheritance of brain cardiolipin fatty acid abnormality 
in VM/DK mice:  Association with hypoxic-induced cognitive insensitivity 	  
 
Introduction 
 
Cardiolipin (1,3-bisphosphatidyl-sn-glycerol, Ptd2Gro) is a complex mitochondrial 
specific phospholipid that regulates numerous enzyme activities especially those 
related to oxidative phosphorylation and coupled respiration (Kiebish et al. 
2008c, Berrigan et al. 2002, Fry et al. 1980, Fry et al. 1981, Chicco et al. 2007, 
Hoch 1992). The activities of the respiratory enzyme complexes and states 1-3 of 
respiration are dependent on Ptd2Gro fatty acid species composition (Kiebish et 
al. 2008b, Chicco et al. 2007, Hoch 1992, Hoch 1998).  Ptd2Gro contains two 
phosphate head groups, three glycerol moieties, and four fatty acyl chains 
(Figure 29).  Ptd2Gro, like many other phospholipids in cellular membranes are 
continually being synthesized and degraded in a dynamic state.  It represents 7-
12 % of total mitochondrial phospholipids (PL) in non-neural tissues and 
approximately 2.5% in the brain (Schlame et al. 2000).  Although the four 
possible acylated positions do provide immense diversity in molecular speciation 
(Schlame et al. 2000, Kiebish et al. 2008a) there is symmetry and specificity in 
the acylated positions.   The specificity can be cell type and tissue specific or 
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even species specific (Schlame et al. 2000).  It varies from rat testis consisting of 
predominantly tetra-palmitoyl (C16:0) to mostly tetra-linoleoyl (C18:2) in rat heart, 
liver and kidney (Wang et al. 2007).  On the other hand, marine bivalves consist 
of predominantly tetra-docosahexaenoyl (C22:6) fatty acids (Kraffe et al. 2002).   
Mouse neural tissue constitutes primarily of C18:1, where tetra-oleoyl fatty acids 
represent high percentage but not the predominant molecular speciation.  There 
is an increase in diversity in molecular speciation in neural tissue rather than the 
tetra-acylated structure seen in non-neural tissues (Kiebish et al. 2008c).  
Nevertheless, the symmetry of the four acylated fatty acids provide structural 
conformation for binding to the ETC complexes, particularly complex III, IV, 
ADP/ATP protein carrier, and aide in the organization of the supramolecular ETC 
complexes (Acehan et al. 2011, Wittig et al. 2009).  The specificity in forming the 
mature cardiolipin in the tetra-acylated structures is seemingly the result of 
deacylation/reacylation or transacylase mechanisms rather than as the result of 
the de novo synthesis pathway.  The uniqueness of this mitochondrial lipids 
association to the ETC enzymatic activities and membrane fluidity ultimately are 
responsible for the functionality and efficiency of respiration.  Alterations in brain 
Ptd2Gro often lead to energetic inefficiency and neurodegenerative diseases 
(Pope et al. 2008a, Daum 1985, Bayir et al. 2007a).  Changes in Ptd2Gro 
abundance or molecular species are observed in traumatic brain injury, 
Parkinson, diabetic cardiomyopathy, heart failure (Pope et al. 2008a, Ellis et al. 
2005).  
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We recently identified over 100 molecular fatty acid species of Ptd2Gro in 
the mitochondria from C57BL/6J (B6) brain, which was similar to the Ptd2Gro 
composition of other mammalian brains (Cheng et al. 2008, Kiebish et al. 2008c).  
In contrast to B6 mice, mice of the VM/Dk (VM) strain have an unusual 
distribution of brain Ptd2Gro molecular species consisting of a greater ratio of 
shorter chain saturated and monounsaturated fatty acids (C16:0; C18:0; C18:1) 
to longer chain polyunsaturated fatty acids (LCPUFA) (C18:2; C20:4; C22:6.)  
Reductions in the activity of mitochondrial respiratory Complexes I, I/III, and II/III 
were linked to the abnormal MUFA/LCPUFA ratio in the VM brain despite normal 
total amounts of total cardiolipin (Kiebish et al. 2008a).   In addition, the incidence 
of spontaneous brain tumors is greater in VM mice than in B6 mice, while the 
onset of p53-induced lymphoma occurs significantly earlier in VM mice than in 
B6/129sv mice (Fraser 1986, van Meyel et al. 1998, Mancuso et al. 2009).  As 
cancer is now recognized as a mitochondrial metabolic disease, this increased 
deficit in mitochondrial function associated with increased cancer incidence could 
be precipitated by the brain Ptd2Gro abnormalities discovered in the VM mice 
(Seyfried 2012, Seyfried et al. 2010b).  
 
In addition to causing energetic abnormalities in tumor cells, alterations in 
brain Ptd2Gro are linked to energetic inefficiency in cardiac and 
neurodegenerative diseases (Pope et al. 2008b, Daum 1985, Bayir et al. 2007b).  
The molecular pathophysiology of cognitive deficiency is incompletely 
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understood.  Currently, 10-15% of children express some level of cognitive 
deficiency that cannot be explained by genetics alone (Thomas et al. 2012, 
Petrosillo et al. 2013).  Due to the wide array of environmental perturbations that 
result in decreased neural bioenergetic efficiency and are likely to alter brain 
mitochondrial lipid composition through peroxidation or altered remodeling, it 
would seem plausible that neural deficiencies might arise from alterations in the 
biophysical properties of the mitochondrial lipid membrane. In this report we 
found that the abnormal distribution of Ptd2Gro molecular species in VM mouse 
brain is inherited as an autosomal dominant trait in crosses with B6 mice and that 
the Ptd2Gro phenotype associates with a behavioral trait involving hypoxia-
induced cognitive insensitivity.	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Materials and Methods 
 
Mice 
 
The VM/DK (VM) strain of mice was obtained originally from H. Fraser (University 
of Edinburgh) and from G. Carlson (McLaughlin Research Institute, Great Falls, 
Montana). The C57BL/6J (B6) mice were obtained from the Jackson Laboratory 
(Bar Harbor, ME). The mice used for the study were maintained in the animal 
facility at Boston College.  Mice of both strains were age matched (three months) 
and both sexes were used for the study.  All mice were individually housed and 
were provided with food under ad libitum (AL).  Water was provided ad libitum to 
all mice.  Whole brain was dissected from the mice following cervical dislocation.  
All animal procedures were in strict accordance with the NIH Guide for the Care 
and Use of Laboratory Animals and were approved by the Institutional Animal 
Care Committee. VM and B6 mice were crossed to produce reciprocal F1 hybrids 
(B6 x VMF1 and VM x B6F1 hybrids).  The female parent is presented on the left 
in each cross.   
 
Hypoxic Treatment 
 
The hypoxia treatment involved placing mice in a partitioned glass 
chromatography jar that was flushed with 5% O2 balanced - N2 (containing 10 
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ppm of ammonia, Air Gas, Cambridge, MA, USA).  The dimensions of the jar 
were as previously described (Seyfried 1979). The mice were treated for a 
maximum of 30 min.  The time of exposure to hypoxia for each mouse was 
dependent on its cognitive sensitivity.  Cognitive sensitivity was assessed by the 
response of a mouse to a gentle tapping sound of 70-72 decibels on the side of 
the glass jar.  Mice responding to the tapping sound show obvious ear and head 
movements.  Mice experiencing hypoxia insensitivity become immobile, lie flat on 
their stomachs, drop their tails, and close their eyes.  As time under hypoxia 
progresses the ear response to the tapping disappears.   Mice that were 
immobile and no longer responsive to the sound were considered cognitively 
insensitive.  The time to insensitivity was recorded for each mouse. 
 
Lipid extraction and fatty acid analysis 
 
The collected mouse brains were stored at -80oC and lyophilized to remove 
water. Total lipids were extracted with chloroform (CHCl3) and methanol (CH3OH) 
1:1 by volume from the lyophilized brain tissue using modifications of previously 
described procedures (Seyfried et al. 1978, Baek et al. 2004, Baek et al. 2008).  
Neutral and acidic lipids were separated using DEAE-Sephadex (A-25, 
Pharmacia Biotech, Upsala, Sweden) column chromatography as previously 
described (Macala et al. 1983).  The total lipid extract, suspended in 
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CHCl3:CH3OH:dH20, 30:60:8 by volume (solvent A), was applied to a DEAE-
Sephadex column (1.2 mL bed volume) that had been equilibrated prior with 
solvent A.   Neutral lipids were eluted with two 20 ml washes of solvent A.  The 
acidic lipids were eluted from the column with 35 mL CHCl3:CH3OH: 0.8 M 
sodium acetate, 30:60:8 by volume.  This fraction contained Ptd2Gro, other acidic 
phospholipids, and sulfatides.  Preparative high performance thin-layer 
chromatography (20 x 20 cm) was used to separate Ptd2Gro from the other 
acidic lipids.  Authentic Ptd2Gro standard, 1',3'-bis(1,2-dioleoyl-sn-glycero-3-
phospho)-sn-glycerol, (Avanti Polar Lipids) was used to identify the Ptd2Gro band 
from the brain samples.  Ptd2Gro visualization was observed after spraying the 
plate with 5% primulin (80:20 acetone: water vol/vol).  The Ptd2Gro fraction was 
scraped from the plate and transesterified with 0.5 N NaOH in methanol for 10 
min in a sealed borosilicate tube under nitrogen at 90oC (Lepage et al. 1984). 
Gas chromatography (HP 6890) equipped with flame ionization detector and 
splitless injector was used for the quantitative analysis of Ptd2Gro fatty acid 
methyl esters.  The fatty acids were resolved using a 30 m x 0.25 mm x 0.25 µm 
Omegawax 250 fused silica capillary column (Supelco). The temperature 
program ramps from 150oC to 220oC at 4oC per minute and was held constant at 
220oC for 20 min. 
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Statistical analysis 
 
The one-way analysis of variance (ANOVA) coupled with Tukey HSD as a post 
hoc test was used to evaluate the significance of differences among the groups 
of mice.   	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Results 
 
The abnormal cardiolipin molecular species composition in VM mice is 
inherited as an autosomal dominant inherited trait 
 
The composition of major brain fatty acid molecular species of Ptd2Gro in the B6 
and the VM parental strains and their reciprocal F1 hybrids is shown in Figure 30.   
No significant differences were found between males and females in the parental 
strains or in the reciprocal F1 hybrids. The mole percent distribution of the major 
saturated and monounsaturated fatty acids (C16:0, C18:0, C18:1) was 
significantly higher in the VM mice than in the B6 mice.  On the other hand the 
mole percent distribution of the major longer chain polyunsaturated fatty acids 
(C18:2; C20:4; C22:6) was significantly lower in the VM mice than in the B6 mice.  
The fatty acid composition of Ptd2Gro was similar in the reciprocal male and 
female F1 hybrids (B6 x VM F1 and VM x B6 F1), indicating the absence of a sex 
influenced or sex-linked trait.  The Ptd2Gro fatty acid distribution in the reciprocal 
F1 hybrids was similar to the distribution in the VM parental strain and 
significantly different from the distribution in the B6 parental strain (Figure 30).  
Consequently the Ptd2Gro MUFA/PUFA ratio and the ratio of shorter chain fatty 
acid (SCFA) to long chain fatty acid (LCFA) (C16-C18)/(C20-C22) were similar in 
the VM parents and F1 hybrids and were significantly higher than the ratios in the 
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B6 parents (Figure 31 A, B).  These findings indicate that the unusual Ptd2Gro 
fatty acid pattern seen in the VM mice was inherited as an autosomal dominant 
trait. 
 
Influence of hypoxia on cognitive sensitivity in the B6 and VM strains and 
their reciprocal F1 hybrids 
 
Cognitive sensitivity in the B6 and the VM parental strains and in their reciprocal 
F1 hybrids under a 5% O2 balanced - N2 enclosed environment (hypoxia) is 
shown in (Figure 31 C).  No differences were seen between male and female 
mice within each strain. The cognitive sensitivity value was significantly lower in 
the VM mice than in the B6 mice. The mean cognitive awareness value for the 
reciprocal male and female F1 hybrids was similar to that in the VM parental 
strain and significantly lower than that in the B6 parental strain.  The autosomal 
dominant pattern of inheritance described above for the distribution of Ptd2Gro 
fatty acids was also seen for cognitive sensitivity under hypoxia, as the pattern of 
inheritance in the reciprocal F1 hybrids was similar to that of the VM parent.  
Viewed together, these findings suggest a genetic association between cognitive 
sensitivity under hypoxia and abnormal Ptd2Gro fatty acid composition.   
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Discussion 
 
In this study, we present evidence showing that the abnormal MUFA/LCPUFA 
and SCFA/LCFA ratios previously reported in mice of the VM strain is inherited 
as an autosomal dominant trait in a cross with the B6 strain.  The mole percent 
distribution of brain Ptd2Gro fatty acid profile of the B6 mice was similar to 
previously reported values, although slightly different due to different methods of 
analysis (Kiebish et al. 2008a, Barcelo-Coblijn et al. 2005).  The brain Ptd2Gro 
fatty acid profile of the B6 mice was also similar to that reported in other 
mammalian brains, suggesting that the brain Ptd2Gro fatty acid profile of VM 
mice is abnormal relative to profile seen in the B6 mice (Cheng et al. 2008, 
Kiebish et al. 2008a).  Similar to Barth syndrome, where a mutation in the 
tafazzin gene produces Ptd2Gro abnormalities, we suggest that the altered 
Ptd2Gro fatty acid pattern in the VM mice could result from alterations in 
cardiolipin remodeling involving acyltransferase(s) and/or phospholipase(s) 
(Vreken et al. 2000, Kiebish et al. 2008a).  It is also possible that the fatty acid 
abnormality in VM mice is due to a defect in an elongase (Jump 2009). 
 
The autosomal dominant inheritance of the abnormal brain Ptd2Gro fatty acid 
profile was also seen for cognitive sensitivity under hypoxia. Cognitive sensitivity 
under hypoxia was significantly less in the VM mice than in the B6 mice.  The 
cognitive sensitivity of the reciprocal male and female B6VMF1 hybrid mice was 
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similar to that of their VM parents and was significantly less than that of their B6 
parents. The absence of differences between the male and female F1 mice for 
Ptd2Gro composition and cognitive sensitivity indicate that these traits are not 
sex linked.  These findings indicate that cognitive sensitivity under hypoxia was 
also inherited as an autosomal dominant trait.  
 
It is well known that impaired cognition can arise as a consequence of impaired 
mitochondrial function (Mancuso et al. 2009, Finsterer 2008).  Moreover, 
cognitive abnormalities were reported previously in mice with deletion of 
phospholipase A2, which plays a role in Ptd2Gro remodeling (Mancuso et al. 
2009).  Ptd2Gro fatty acid species composition is known to influence the activities 
of the respiratory enzyme complexes and states 1-3 of respiration.  It is therefore 
possible that the abnormal brain Ptd2Gro fatty acid composition and possibly that 
of other phospholipids in VM mice underlies the abnormal cognitive sensitivity to 
hypoxia in this strain and in their F1 hybrids (Claypool et al. 2011).  Further 
studies will be needed to determine if the dominant inheritance of the 
abnormalities in Ptd2Gro composition and if cognitive insensitivity is due to the 
action of a single dominant gene or whether it is due to a multifactorial trait with 
dominant inheritance (Todorova et al. 2006, Todorova et al. 1999).  It is unknown 
if the differences in Ptd2Gro between VM, F1 hybrids and B6 occurred only 
specifically in the brain.  Further studies will be needed to determine if the 
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differences could occur in other tissues and how hypoxia can influence Ptd2Gro 
fatty acid composition in the brain and other tissues.  
  
	   130	  
Summary 
 
In this study we found that the abnormal brain fatty acid ratio in the VM strain 
was inherited as an autosomal dominant trait in reciprocal B6 x VM F1 hybrids. 
Cognitive awareness (conscientiousness) under hypoxia was significantly lower 
in the VM parental mice and F1 hybrid mice than in the parental B6 mice, 
indicating an autosomal dominant inheritance like that of the brain Ptd2Gro 
abnormalities.  These findings suggest that impaired cognitive awareness under 
hypoxia is associated with abnormalities in neural lipid composition.  
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Tables and Figures 
 
Figure 29. Structure of Ptd2Gro 
	  
Structure of Ptd2Gro (1,3-diphosphatidyl-sn-glycerol) 
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Figure 29. 
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Figure 30. The composition of major brain fatty acid molecular species of Ptd2Gro 
in B6 and VM parental strains and their reciprocal F1 hybrids 
 
The composition of major brain fatty acid molecular species of Ptd2Gro in B6 and 
VM parental strains and their reciprocal F1 hybrids.  Values represent mole 
percent distribution of fatty acid ± SEM.  Significant differences from B6 at * p < 
0.01 as determined by ANOVA coupled with Tukey HSD as a post hoc test.   
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Figure 30. 
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Figure 31 The proportionality of SCFA/LCFA and MUFA/PUFA is associated with 
cognitive sensitivity 
 
The proportionality of SCFA/LCFA (A) and MUFA/PUFA (B) is associated with 
cognitive sensitivity (C). Shorter chain fatty acids (SCFA) represent fatty acids 
ranging from C16-C18.  Longer chain fatty acids (LCFA) represent fatty acids 
ranging from C20-C22.  Monounsaturated fatty acids (MUFA) represent C16:1, 
C18:1.  Polyunsaturated fatty acids (PUFA) represent C18-2 n-6, C20:3, C20:4 n-
6, C22:6 n-3.  B6, VM and F1 hybrid mice were treated for cognitive sensitivity as 
described in Methods. Values represent the mean ± SEM. Asterisks indicate that 
the values differ significantly from the values in B6 mice at ٭p < 0.01 as 
determined by one-way ANOVA coupled with Tukey HSD as a post hoc test. n 
denotes number of independent mice analyzed.  
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Figure 31. 
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